ID AMRSAPFCS1 PN Cath-BF SO Bungarus fasciatus. PL 34 TX Animalia (Reptile) PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 1, 'F': 6, 'G': 1, 'H': 0, 'I': 2, 'K': 11, 'L': 1, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 4, 'S': 2, 'T': 0, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 2.94%, 'C': 0%, 'D': 0%, 'E': 2.94%, 'F': 17.65%, 'G': 2.94%, 'H': 0%, 'I': 5.88%, 'K': 32.35%, 'L': 2.94%, AF 'M': 0%, 'N': 0%, 'P': 5.88%, 'Q': 0%, 'R': 11.76%, 'S': 5.88%, 'T': 0%, 'V': 8.82%, 'W': 0%, 'Y': 0% MA C, D, H, M, N, Q, T, W, Y MO K LO A, E, G, L BA 16 LA 18 AA 1 BC 15 MC 0 MF 0 XX MM 4198.252 AI 62.941 II 14.582 HP -0.753 HM 0.904 IP 12.579 NC 13.997 SF 0.353, 0.147, 0.088 [Helix, Turn, Sheet] AR 0.176 ME 0, 0 MS 90.301935 XX SC alpha XX TO Clinical MRSA strains PS2 (Isolated in Pediatric infections Research Center) (MIC= 64 μG/mL) XX XR PubMed: 29392557 XR CAMP R4: CAMPSQ10023 SQ SEQUENCE 4198.252 DA MW 34AA KRFKKFFRKL KKSVKKRAKE FFKKPRVIGV SIPF // ID AMRSAPFCS2 PN Cath-A SO Synthetic construct PL 34 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 1, 'F': 5, 'G': 0, 'H': 0, 'I': 2, 'K': 14, 'L': 1, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 4, 'S': 2, 'T': 0, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 2.94%, 'F': 14.71%, 'G': 0%, 'H': 0%, 'I': 5.88%, 'K': 41.18%, 'L': 2.94%, AF 'M': 0%, 'N': 0%, 'P': 5.88%, 'Q': 0%, 'R': 11.76%, 'S': 5.88%, 'T': 0%, 'V': 8.82%, 'W': 0%, 'Y': 0% MA A, C, D, G, H, M, N, Q, T, W, Y MO K LO E, L BA 13 LA 21 AA 1 BC 18 MC 0 MF 0 XX MM 4307.467 AI 60 II 9.588 HP -1.221 HM 0.904 IP 12.596 NC 16.996 SF 0.324, 0.118, 0.059 [Helix, Turn, Sheet] AR 0.147 ME 0, 0 MS 108.362322 XX SC alpha XX TO Clinical MRSA strains PS2 (Isolated in Pediatric infections Research Center) (MIC= 64 μG/mL) XX XR PubMed: 29392557 XR CAMP R4: CAMPSQ10024 SQ SEQUENCE 4307.467 DA MW 34AA KRFKKFFRKL KKSVKKRKKE FKKKPRVIKV SIPF // ID AMRSAPFCS3 PN Cath-B SO Synthetic construct PL 34 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 1, 'F': 5, 'G': 1, 'H': 0, 'I': 2, 'K': 13, 'L': 1, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 4, 'S': 2, 'T': 0, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 2.94%, 'F': 14.71%, 'G': 2.94%, 'H': 0%, 'I': 5.88%, 'K': 38.24%, 'L': 2.94%, AF 'M': 0%, 'N': 0%, 'P': 5.88%, 'Q': 0%, 'R': 11.76%, 'S': 5.88%, 'T': 0%, 'V': 8.82%, 'W': 0%, 'Y': 0% MA A, C, D, H, M, N, Q, T, W, Y MO K LO E, G, L BA 14 LA 20 AA 1 BC 17 MC 0 MF 0 XX MM 4236.345 AI 60 II 14.582 HP -1.118 HM 0.904 IP 12.59 NC 15.996 SF 0.324, 0.147, 0.059 [Helix, Turn, Sheet] AR 0.147 ME 0, 0 MS 102.342193 XX SC alpha_beta XX TO Clinical MRSA strains PS2 (Isolated in Pediatric infections Research Center) (MIC= 256 μG/mL) XX XR PubMed: 29392557 XR CAMP R4: CAMPSQ10025 SQ SEQUENCE 4236.345 DA MW 34AA KRFKKFFRKL KKSVKKRKKE FKKKPRVIGV SIPF // ID AMRSAPFCS4 PN DP7 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 2, 'K': 1, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 3, 'S': 0, 'T': 0, 'V': 3, 'W': 1, 'Y': 0 AF 'A': 8.33%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 16.67%, 'K': 8.33%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 8.33%, 'R': 25%, 'S': 0%, 'T': 0%, 'V': 25%, 'W': 8.33%, 'Y': 0% MA C, D, E, F, G, H, L, M, N, P, S, T, Y MO R; V LO A, K, Q, W BA 7 LA 5 AA 0 BC 4 MC 0 MF 0 XX MM 1523.891 AI 145.833 II 9.167 HP 0.133 HM 0.265 IP 12.807 NC 3.998 SF 0.5, 0, 0.083 [Helix, Turn, Sheet] AR 0.083 ME 5500, 5500 MS 24.080516 XX SC beta XX TO S. aureus clinical isolates (MRSA SCQ1) (MIC = 16.32 mg/L) (MBC = 128.256 mg/L) XX XR PubMed: 31191493 XR CAMP R4: CAMPSQ10540 SQ SEQUENCE 1523.891 DA MW 12AA VQWRIRVAVI RK // ID AMRSAPFCS5 PN DP7 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 2, 'K': 1, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 3, 'S': 0, 'T': 0, 'V': 3, 'W': 1, 'Y': 0 AF 'A': 8.33%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 16.67%, 'K': 8.33%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 8.33%, 'R': 25%, 'S': 0%, 'T': 0%, 'V': 25%, 'W': 8.33%, 'Y': 0% MA C, D, E, F, G, H, L, M, N, P, S, T, Y MO R; V LO A, K, Q, W BA 7 LA 5 AA 0 BC 4 MC 0 MF 0 XX MM 1523.891 AI 145.833 II 9.167 HP 0.133 HM 0.265 IP 12.807 NC 3.998 SF 0.5, 0, 0.083 [Helix, Turn, Sheet] AR 0.083 ME 5500, 5500 MS 24.080516 XX SC beta XX TO S. aureus clinical isolates (MRSA) (S3768) (MIC=32mg/L) (MBC= 256mg/L) XX XR PubMed: 31191493 XR CAMP R4: CAMPSQ10540 SQ SEQUENCE 1523.891 DA MW 12AA VQWRIRVAVI RK // ID AMRSAPFCS6 PN Skh-AMP1 SO Satureja khuzistanica PL 25 TX Plantae PE Experimentally validated XX AC 'A': 2, 'C': 1, 'D': 1, 'E': 2, 'F': 0, 'G': 3, 'H': 0, 'I': 1, 'K': 2, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 2, 'R': 3, 'S': 2, 'T': 3, 'V': 1, 'W': 1, 'Y': 0 AF 'A': 8%, 'C': 4%, 'D': 4%, 'E': 8%, 'F': 0%, 'G': 12%, 'H': 0%, 'I': 4%, 'K': 8%, 'L': 4%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 8%, 'R': 12%, 'S': 8%, 'T': 12%, 'V': 4%, 'W': 4%, 'Y': 0% MA F, H, M, N, P, Y MO G; R; T LO C, D, I, L, V, W BA 9 LA 16 AA 3 BC 5 MC 0 MF 0 XX MM 2778.095 AI 50.8 II 31.32 HP -1.04 HM 0.646 IP 9.669 NC 1.939 SF 0.16, 0.2, 0.2 [Helix, Turn, Sheet] AR 0.04 ME 5500, 5500 MS 30.100645 XX SC beta XX TO S. aureus clinical isolates (MRSA SCQ3) (MIC = 16.32 mg/L) (MBC = 128.256 mg/L) XX XR PubMed: 31191493 XR CAMP R4: CAMPSQ10541 SQ SEQUENCE 2778.095 DA MW 25AA GRTSKQELCT WERGSVRQAD KTIAG // ID AMRSAPFCS7 PN PepR SO Dengue virus PL 35 TX Virus PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 1, 'F': 1, 'G': 3, 'H': 0, 'I': 4, 'K': 5, 'L': 4, AC 'M': 1, 'N': 3, 'P': 0, 'Q': 0, 'R': 8, 'S': 1, 'T': 1, 'V': 1, 'W': 1, 'Y': 0 AF 'A': 2.86%, 'C': 0%, 'D': 0%, 'E': 2.86%, 'F': 2.86%, 'G': 8.57%, 'H': 0%, 'I': 11.43%, 'K': 14.29%, 'L': 11.43%, AF 'M': 2.86%, 'N': 8.57%, 'P': 0%, 'Q': 0%, 'R': 22.86%, 'S': 2.86%, 'T': 2.86%, 'V': 2.86%, 'W': 2.86%, 'Y': 0% MA C, D, H, P, Q, Y MO R LO A, E, F, M, S, T, V, W BA 16 LA 19 AA 1 BC 13 MC 0 MF 0 XX MM 4279.221 AI 100.286 II 100.889 HP -0.834 HM 0.757 IP 12.987 NC 11.998 SF 0.314, 0.2, 0.2 [Helix, Turn, Sheet] AR 0.057 ME 5500, 5500 MS 78.261677 XX SC beta XX TO S. aureus clinical isolates (MRSA S150320016) (MIC = 16.32 mg/L) (MBC = 128.256 mg/L) XX XR PubMed: 31191493 XR CAMP R4: CAMPSQ10542 SQ SEQUENCE 4279.221 DA MW 35AA LKRWGTIKKS KAINVLRGFR KEIGRMLNIL NRRRR // ID AMRSAPFCS8 PN Cm-CATH1 SO Chelonia mydas PL 40 TX Animalia PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 8, 'H': 1, 'I': 4, 'K': 6, 'L': 5, AC 'M': 1, 'N': 0, 'P': 2, 'Q': 3, 'R': 7, 'S': 1, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 2.5%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 2.5%, 'G': 20%, 'H': 2.5%, 'I': 10%, 'K': 15%, 'L': 12.5%, AF 'M': 2.5%, 'N': 0%, 'P': 5%, 'Q': 7.5%, 'R': 17.5%, 'S': 2.5%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, N, T, V, W, Y MO G LO A, F, H, M, S BA 22 LA 18 AA 0 BC 14 MC 0 MF 0 XX MM 4507.515 AI 90.25 II 64.763 HP -0.808 HM 0.955 IP 13.288 NC 13.087 SF 0.25, 0.275, 0.175 [Helix, Turn, Sheet] AR 0.025 ME 0, 0 MS 78.261677 XX SC alpha XX TO S. aureus clinical isolates (MRSA S3250016) (MIC = 16.32 mg/L) (MBC = 128.256 mg/L) XX XR PubMed: 31191493 XR CAMP R4: CAMPSQ10543 SQ SEQUENCE 4507.515 DA MW 40AA RRSIFRKLRR KIKKGLKKGI QHLLAGGRQG LPQGGRPGMI // ID AMRSAPFCS9 PN Cm-CATH2 SO Chelonia mydas PL 33 TX Animalia PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 4, 'G': 4, 'H': 1, 'I': 1, 'K': 3, 'L': 2, AC 'M': 1, 'N': 0, 'P': 0, 'Q': 1, 'R': 10, 'S': 2, 'T': 1, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.12%, 'G': 12.12%, 'H': 3.03%, 'I': 3.03%, 'K': 9.09%, 'L': 6.06%, AF 'M': 3.03%, 'N': 0%, 'P': 0%, 'Q': 3.03%, 'R': 30.3%, 'S': 6.06%, 'T': 3.03%, 'V': 9.09%, 'W': 0%, 'Y': 0% MA A, C, D, E, N, P, W, Y MO R LO H, I, M, Q, T BA 15 LA 18 AA 0 BC 14 MC 0 MF 0 XX MM 4089.928 AI 61.818 II 62.645 HP -0.894 HM 0.86 IP 13.457 NC 13.088 SF 0.303, 0.182, 0.091 [Helix, Turn, Sheet] AR 0.121 ME 0, 0 MS 78.261677 XX SC alpha XX TO S. aureus clinical isolates (MRSA S3396) (MIC = 16.32 mg/L) (MBC = 128.256 mg/L) XX XR PubMed: 31191493 XR CAMP R4: CAMPSQ10544 SQ SEQUENCE 4089.928 DA MW 33AA RRSRFGRFFK KVRKQLGRVL RHSRITVGGR MRF // ID AMRSAPFCS10 PN Cm-CATH3 SO Chelonia mydas PL 33 TX Animalia PE Experimentally validated XX AC 'A': 3, 'C': 0, 'D': 1, 'E': 1, 'F': 3, 'G': 3, 'H': 1, 'I': 3, 'K': 3, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 8, 'S': 1, 'T': 1, 'V': 2, 'W': 2, 'Y': 0 AF 'A': 9.09%, 'C': 0%, 'D': 3.03%, 'E': 3.03%, 'F': 9.09%, 'G': 9.09%, 'H': 3.03%, 'I': 9.09%, 'K': 9.09%, 'L': 3.03%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 24.24%, 'S': 3.03%, 'T': 3.03%, 'V': 6.06%, 'W': 6.06%, 'Y': 0% MA C, M, N, P, Q, Y MO R LO D, E, H, L, S, T BA 17 LA 16 AA 2 BC 12 MC 0 MF 0 XX MM 4070.817 AI 73.939 II 49.885 HP -0.694 HM 1.083 IP 12.73 NC 9.09 SF 0.333, 0.121, 0.152 [Helix, Turn, Sheet] AR 0.152 ME 11000, 11000 MS 66.221419 XX SC alpha_beta XX TO S. aureus clinical isolates (MRSA S3750) (MIC = 16.32 mg/L) (MBC = 128.256 mg/L) XX XR PubMed: 31191493 XR CAMP R4: CAMPSQ10545 SQ SEQUENCE 4070.817 DA MW 33AA TRGRWKRFWR GAGRFFRRHK EKIIRAAVDI VLS // ID AMRSAPFCS11 PN Cm-CATH4 SO Chelonia mydas PL 51 TX Animalia PE Experimentally validated XX AC 'A': 8, 'C': 0, 'D': 1, 'E': 3, 'F': 2, 'G': 4, 'H': 1, 'I': 4, 'K': 1, 'L': 7, AC 'M': 1, 'N': 2, 'P': 4, 'Q': 2, 'R': 2, 'S': 3, 'T': 3, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 15.69%, 'C': 0%, 'D': 1.96%, 'E': 5.88%, 'F': 3.92%, 'G': 7.84%, 'H': 1.96%, 'I': 7.84%, 'K': 1.96%, 'L': 13.73%, AF 'M': 1.96%, 'N': 3.92%, 'P': 7.84%, 'Q': 3.92%, 'R': 3.92%, 'S': 5.88%, 'T': 5.88%, 'V': 5.88%, 'W': 0%, 'Y': 0% MA C, W, Y MO A LO D, H, K, M BA 33 LA 18 AA 4 BC 4 MC 0 MF 0 XX MM 5300.161 AI 116.863 II 39.788 HP 0.441 HM 0.5 IP 5.617 NC -0.906 SF 0.314, 0.255, 0.373 [Helix, Turn, Sheet] AR 0.039 ME 0, 0 MS 18.060387 XX SC beta XX TO S. aureus clinical isolates (MRSA S260029) (MIC = 16.32 mg/L) (MBC = 128.256 mg/L) XX XR PubMed: 31191493 XR CAMP R4: CAMPSQ10546 SQ SEQUENCE 5300.161 DA MW 51AA MAFPFSTQRI NPEIEEGNAS LADLPVTHAG SLPGIKAQVR TALGIALLLV A // ID AMRSAPFCS12 PN H27 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 1, 'K': 5, 'L': 3, AC 'M': 1, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 8.33%, 'H': 0%, 'I': 8.33%, 'K': 41.67%, 'L': 25%, AF 'M': 8.33%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 8.33%, 'Y': 0% MA A, C, D, E, F, H, N, P, Q, R, S, T, V, Y MO K LO G, I, M, W BA 7 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 1485.981 AI 130 II 9.575 HP -0.25 HM 0.836 IP 11.403 NC 4.997 SF 0.417, 0.083, 0.333 [Helix, Turn, Sheet] AR 0.083 ME 5500, 5500 MS 30.100645 XX SC alpha_beta XX TO MRSA (Clinical isolate from Liberec Regional Hospital) (MIC = 3.6 μM/L) XX XR PubMed: 31107198 XR CAMP R4: CAMPSQ10604 SQ SEQUENCE 1485.981 DA MW 12AA GKWMKLLKKI LK // ID AMRSAPFCS13 PN H27 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 1, 'K': 5, 'L': 3, AC 'M': 1, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 8.33%, 'H': 0%, 'I': 8.33%, 'K': 41.67%, 'L': 25%, AF 'M': 8.33%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 8.33%, 'Y': 0% MA A, C, D, E, F, H, N, P, Q, R, S, T, V, Y MO K LO G, I, M, W BA 7 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 1485.981 AI 130 II 9.575 HP -0.25 HM 0.836 IP 11.403 NC 4.997 SF 0.417, 0.083, 0.333 [Helix, Turn, Sheet] AR 0.083 ME 5500, 5500 MS 30.100645 XX SC alpha_beta XX TO MRSA (Clinical isolate from Motol University Hospital) (MIC = 5.7 μM/L) XX XR PubMed: 31107198 XR CAMP R4: CAMPSQ10604 SQ SEQUENCE 1485.981 DA MW 12AA GKWMKLLKKI LK // ID AMRSAPFCS14 PN H27D SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 1, 'K': 5, 'L': 3, AC 'M': 1, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 8.33%, 'H': 0%, 'I': 8.33%, 'K': 41.67%, 'L': 25%, AF 'M': 8.33%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 8.33%, 'Y': 0% MA A, C, D, E, F, H, N, P, Q, R, S, T, V, Y MO K LO G, I, M, W BA 7 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 1485.981 AI 130 II 9.575 HP -0.25 HM 0.836 IP 11.403 NC 4.997 SF 0.417, 0.083, 0.333 [Helix, Turn, Sheet] AR 0.083 ME 5500, 5500 MS 30.100645 XX SC alpha_beta XX TO MRSA (Clinical isolate from Liberec Regional Hospital) (MIC = 5.3 μM/L) XX XR PubMed: 31107198 XR CAMP R4: CAMPSQ10605 SQ SEQUENCE 1485.981 DA MW 12AA GKWMKLLKKI LK // ID AMRSAPFCS15 PN H27D SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 1, 'K': 5, 'L': 3, AC 'M': 1, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 8.33%, 'H': 0%, 'I': 8.33%, 'K': 41.67%, 'L': 25%, AF 'M': 8.33%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 8.33%, 'Y': 0% MA A, C, D, E, F, H, N, P, Q, R, S, T, V, Y MO K LO G, I, M, W BA 7 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 1485.981 AI 130 II 9.575 HP -0.25 HM 0.836 IP 11.403 NC 4.997 SF 0.417, 0.083, 0.333 [Helix, Turn, Sheet] AR 0.083 ME 5500, 5500 MS 30.100645 XX SC alpha_beta XX TO MRSA (Clinical isolate from Motol University Hospital) (MIC = 9.7 μM/L) XX XR PubMed: 31107198 XR CAMP R4: CAMPSQ10605 SQ SEQUENCE 1485.981 DA MW 12AA GKWMKLLKKI LK // ID AMRSAPFCS16 PN H39 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 1, 'K': 5, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 8.33%, 'H': 0%, 'I': 8.33%, 'K': 41.67%, 'L': 25%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 8.33%, 'W': 8.33%, 'Y': 0% MA A, C, D, E, F, H, M, N, P, Q, R, S, T, Y MO K LO G, I, V, W BA 7 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 1453.921 AI 154.167 II -19.633 HP -0.058 HM 0.845 IP 11.403 NC 4.997 SF 0.5, 0.083, 0.25 [Helix, Turn, Sheet] AR 0.083 ME 5500, 5500 MS 30.100645 XX SC alpha_beta XX TO MRSA (Clinical isolate from Liberec Regional Hospital) (MIC = 5.0 μM/L) XX XR PubMed: 31107198 XR CAMP R4: CAMPSQ10606 SQ SEQUENCE 1453.921 DA MW 12AA GKWVKLLKKI LK // ID AMRSAPFCS17 PN H39 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 1, 'K': 5, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 8.33%, 'H': 0%, 'I': 8.33%, 'K': 41.67%, 'L': 25%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 8.33%, 'W': 8.33%, 'Y': 0% MA A, C, D, E, F, H, M, N, P, Q, R, S, T, Y MO K LO G, I, V, W BA 7 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 1453.921 AI 154.167 II -19.633 HP -0.058 HM 0.845 IP 11.403 NC 4.997 SF 0.5, 0.083, 0.25 [Helix, Turn, Sheet] AR 0.083 ME 5500, 5500 MS 30.100645 XX SC alpha_beta XX TO MRSA (Clinical isolate from Motol University Hospital) (MIC = 10.0 μM/L) XX XR PubMed: 31107198 XR CAMP R4: CAMPSQ10606 SQ SEQUENCE 1453.921 DA MW 12AA GKWVKLLKKI LK // ID AMRSAPFCS18 PN H39D SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 1, 'K': 5, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 8.33%, 'H': 0%, 'I': 8.33%, 'K': 41.67%, 'L': 25%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 8.33%, 'W': 8.33%, 'Y': 0% MA A, C, D, E, F, H, M, N, P, Q, R, S, T, Y MO K LO G, I, V, W BA 7 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 1453.921 AI 154.167 II -19.633 HP -0.058 HM 0.845 IP 11.403 NC 4.997 SF 0.5, 0.083, 0.25 [Helix, Turn, Sheet] AR 0.083 ME 5500, 5500 MS 30.100645 XX SC alpha_beta XX TO MRSA (Clinical isolate from Liberec Regional Hospital) (MIC = 15.0 μM/L) XX XR PubMed: 31107198 XR CAMP R4: CAMPSQ10607 SQ SEQUENCE 1453.921 DA MW 12AA GKWVKLLKKI LK // ID AMRSAPFCS19 PN H39D SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 1, 'K': 5, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 8.33%, 'H': 0%, 'I': 8.33%, 'K': 41.67%, 'L': 25%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 8.33%, 'W': 8.33%, 'Y': 0% MA A, C, D, E, F, H, M, N, P, Q, R, S, T, Y MO K LO G, I, V, W BA 7 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 1453.921 AI 154.167 II -19.633 HP -0.058 HM 0.845 IP 11.403 NC 4.997 SF 0.5, 0.083, 0.25 [Helix, Turn, Sheet] AR 0.083 ME 5500, 5500 MS 30.100645 XX SC alpha_beta XX TO MRSA (Clinical isolate from Motol University Hospital) (MIC = 22.0 μM/L) XX XR PubMed: 31107198 XR CAMP R4: CAMPSQ10607 SQ SEQUENCE 1453.921 DA MW 12AA GKWVKLLKKI LK // ID AMRSAPFCS20 PN H39LD SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 1, 'K': 5, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 8.33%, 'H': 0%, 'I': 8.33%, 'K': 41.67%, 'L': 25%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 8.33%, 'W': 8.33%, 'Y': 0% MA A, C, D, E, F, H, M, N, P, Q, R, S, T, Y MO K LO G, I, V, W BA 7 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 1453.921 AI 154.167 II -19.633 HP -0.058 HM 0.845 IP 11.403 NC 4.997 SF 0.5, 0.083, 0.25 [Helix, Turn, Sheet] AR 0.083 ME 5500, 5500 MS 30.100645 XX SC alpha_beta XX TO MRSA (Clinical isolate from Liberec Regional Hospital) (MIC >= 100 μM/L) XX XR PubMed: 31107198 XR CAMP R4: CAMPSQ10608 SQ SEQUENCE 1453.921 DA MW 12AA GKWVKLLKKI LK // ID AMRSAPFCS21 PN H39LD SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 1, 'K': 5, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 8.33%, 'H': 0%, 'I': 8.33%, 'K': 41.67%, 'L': 25%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 8.33%, 'W': 8.33%, 'Y': 0% MA A, C, D, E, F, H, M, N, P, Q, R, S, T, Y MO K LO G, I, V, W BA 7 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 1453.921 AI 154.167 II -19.633 HP -0.058 HM 0.845 IP 11.403 NC 4.997 SF 0.5, 0.083, 0.25 [Helix, Turn, Sheet] AR 0.083 ME 5500, 5500 MS 30.100645 XX SC alpha_beta XX TO MRSA (Clinical isolate from Motol University Hospital) (MIC >= 100 μM/L) XX XR PubMed: 31107198 XR CAMP R4: CAMPSQ10608 SQ SEQUENCE 1453.921 DA MW 12AA GKWVKLLKKI LK // ID AMRSAPFCS22 PN EcDBS1R5 SO Synthetic construct PL 19 TX Synthetic construct PE Experimentally validated XX AC 'A': 4, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 1, 'K': 4, 'L': 4, AC 'M': 1, 'N': 0, 'P': 2, 'Q': 0, 'R': 1, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 0 AF 'A': 21.05%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 5.26%, 'K': 21.05%, 'L': 21.05%, AF 'M': 5.26%, 'N': 0%, 'P': 10.53%, 'Q': 0%, 'R': 5.26%, 'S': 0%, 'T': 0%, 'V': 5.26%, 'W': 5.26%, 'Y': 0% MA C, D, E, F, G, H, N, Q, S, T, Y MO A; K; L LO I, M, R, V, W BA 14 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 2147.783 AI 138.947 II 18.042 HP 0.463 HM 0.674 IP 11.997 NC 4.997 SF 0.368, 0.105, 0.474 [Helix, Turn, Sheet] AR 0.053 ME 5500, 5500 MS 30.100645 XX SC alpha_beta XX TO MRSA (clinical isolate 713623) (MIC = 32 μM) XX XR PubMed: 30346140 XR CAMP R4: CAMPSQ11242 SQ SEQUENCE 2147.783 DA MW 19AA PMKKLKLALR LAAKIAPVW // ID AMRSAPFCS23 PN Ba49 SO Bacillus subtilis subsp. spizizenii PL 32 TX Monera PE Experimentally validated XX AC 'A': 1, 'C': 5, 'D': 0, 'E': 1, 'F': 1, 'G': 2, 'H': 0, 'I': 1, 'K': 3, 'L': 4, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 2, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 0 AF 'A': 4.17%, 'C': 20.83%, 'D': 0%, 'E': 4.17%, 'F': 4.17%, 'G': 8.33%, 'H': 0%, 'I': 4.17%, 'K': 12.5%, 'L': 16.67%, AF 'M': 0%, 'N': 4.17%, 'P': 4.17%, 'Q': 8.33%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 4.17%, 'W': 4.17%, 'Y': 0% MA D, H, M, R, S, T, Y MO C; O LO A, E, F, I, N, P, V, W BA 12 LA 12 AA 1 BC 3 MC {'O': 5, 'J': 3} MF {'O': 0.15625, 'J': 0.09375} XX MM 3884.84 AI 109.688 II 21.5 HP 0.375 HM 0.348 IP 8.213 NC 1.689 SF 0.25, 0.125, 0.188 [Helix, Turn, Sheet] AR 0.063 ME 5500, 5750 MS 18.060387 XX SC beta XX TO MRSA 831 Clinical isolate (MIC = 16 μM) XX XR PubMed: 33427970 XR CAMP R4: CAMPSQ14322 SQ SEQUENCE 3884.84 DA MW 32AA WKJEJLCOPG CVOGALQOCF LQOLOCNCKI JK // ID AMRSAPFCS24 PN Ba49 SO Bacillus subtilis subsp. spizizenii PL 32 TX Monera PE Experimentally validated XX AC 'A': 1, 'C': 5, 'D': 0, 'E': 1, 'F': 1, 'G': 2, 'H': 0, 'I': 1, 'K': 3, 'L': 4, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 2, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 0 AF 'A': 4.17%, 'C': 20.83%, 'D': 0%, 'E': 4.17%, 'F': 4.17%, 'G': 8.33%, 'H': 0%, 'I': 4.17%, 'K': 12.5%, 'L': 16.67%, AF 'M': 0%, 'N': 4.17%, 'P': 4.17%, 'Q': 8.33%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 4.17%, 'W': 4.17%, 'Y': 0% MA D, H, M, R, S, T, Y MO C; O LO A, E, F, I, N, P, V, W BA 12 LA 12 AA 1 BC 3 MC {'O': 5, 'J': 3} MF {'O': 0.15625, 'J': 0.09375} XX MM 3884.84 AI 109.688 II 21.5 HP 0.375 HM 0.348 IP 8.213 NC 1.689 SF 0.25, 0.125, 0.188 [Helix, Turn, Sheet] AR 0.063 ME 5500, 5750 MS 18.060387 XX SC beta XX TO MRSA 839 Clinical isolate (MIC = 16 μM) XX XR PubMed: 33427970 XR CAMP R4: CAMPSQ14322 SQ SEQUENCE 3884.84 DA MW 32AA WKJEJLCOPG CVOGALQOCF LQOLOCNCKI JK // ID AMRSAPFCS25 PN Ba49 SO Bacillus subtilis subsp. spizizenii PL 32 TX Monera PE Experimentally validated XX AC 'A': 1, 'C': 5, 'D': 0, 'E': 1, 'F': 1, 'G': 2, 'H': 0, 'I': 1, 'K': 3, 'L': 4, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 2, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 0 AF 'A': 4.17%, 'C': 20.83%, 'D': 0%, 'E': 4.17%, 'F': 4.17%, 'G': 8.33%, 'H': 0%, 'I': 4.17%, 'K': 12.5%, 'L': 16.67%, AF 'M': 0%, 'N': 4.17%, 'P': 4.17%, 'Q': 8.33%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 4.17%, 'W': 4.17%, 'Y': 0% MA D, H, M, R, S, T, Y MO C; O LO A, E, F, I, N, P, V, W BA 12 LA 12 AA 1 BC 3 MC {'O': 5, 'J': 3} MF {'O': 0.15625, 'J': 0.09375} XX MM 3884.84 AI 109.688 II 21.5 HP 0.375 HM 0.348 IP 8.213 NC 1.689 SF 0.25, 0.125, 0.188 [Helix, Turn, Sheet] AR 0.063 ME 5500, 5750 MS 18.060387 XX SC beta XX TO MRSA 1 Clinical isolate (MIC = 2 μM) XX XR PubMed: 33427970 XR CAMP R4: CAMPSQ14322 SQ SEQUENCE 3884.84 DA MW 32AA WKJEJLCOPG CVOGALQOCF LQOLOCNCKI JK // ID AMRSAPFCS26 PN Ba49 SO Bacillus subtilis subsp. spizizenii PL 32 TX Monera PE Experimentally validated XX AC 'A': 1, 'C': 5, 'D': 0, 'E': 1, 'F': 1, 'G': 2, 'H': 0, 'I': 1, 'K': 3, 'L': 4, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 2, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 0 AF 'A': 4.17%, 'C': 20.83%, 'D': 0%, 'E': 4.17%, 'F': 4.17%, 'G': 8.33%, 'H': 0%, 'I': 4.17%, 'K': 12.5%, 'L': 16.67%, AF 'M': 0%, 'N': 4.17%, 'P': 4.17%, 'Q': 8.33%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 4.17%, 'W': 4.17%, 'Y': 0% MA D, H, M, R, S, T, Y MO C; O LO A, E, F, I, N, P, V, W BA 12 LA 12 AA 1 BC 3 MC {'O': 5, 'J': 3} MF {'O': 0.15625, 'J': 0.09375} XX MM 3884.84 AI 109.688 II 21.5 HP 0.375 HM 0.348 IP 8.213 NC 1.689 SF 0.25, 0.125, 0.188 [Helix, Turn, Sheet] AR 0.063 ME 5500, 5750 MS 18.060387 XX SC beta XX TO MRSA 2 Clinical isolate (MIC = 2 μM) XX XR PubMed: 33427970 XR CAMP R4: CAMPSQ14322 SQ SEQUENCE 3884.84 DA MW 32AA WKJEJLCOPG CVOGALQOCF LQOLOCNCKI JK // ID AMRSAPFCS27 PN Ba49 SO Bacillus subtilis subsp. spizizenii PL 32 TX Monera PE Experimentally validated XX AC 'A': 1, 'C': 5, 'D': 0, 'E': 1, 'F': 1, 'G': 2, 'H': 0, 'I': 1, 'K': 3, 'L': 4, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 2, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 0 AF 'A': 4.17%, 'C': 20.83%, 'D': 0%, 'E': 4.17%, 'F': 4.17%, 'G': 8.33%, 'H': 0%, 'I': 4.17%, 'K': 12.5%, 'L': 16.67%, AF 'M': 0%, 'N': 4.17%, 'P': 4.17%, 'Q': 8.33%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 4.17%, 'W': 4.17%, 'Y': 0% MA D, H, M, R, S, T, Y MO C; O LO A, E, F, I, N, P, V, W BA 12 LA 12 AA 1 BC 3 MC {'O': 5, 'J': 3} MF {'O': 0.15625, 'J': 0.09375} XX MM 3884.84 AI 109.688 II 21.5 HP 0.375 HM 0.348 IP 8.213 NC 1.689 SF 0.25, 0.125, 0.188 [Helix, Turn, Sheet] AR 0.063 ME 5500, 5750 MS 18.060387 XX SC beta XX TO MRSA 3 Clinical isolate (MIC = 8 μM) XX XR PubMed: 33427970 XR CAMP R4: CAMPSQ14322 SQ SEQUENCE 3884.84 DA MW 32AA WKJEJLCOPG CVOGALQOCF LQOLOCNCKI JK // ID AMRSAPFCS28 PN Ba49 SO Bacillus subtilis subsp. spizizenii PL 32 TX Monera PE Experimentally validated XX AC 'A': 1, 'C': 5, 'D': 0, 'E': 1, 'F': 1, 'G': 2, 'H': 0, 'I': 1, 'K': 3, 'L': 4, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 2, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 0 AF 'A': 4.17%, 'C': 20.83%, 'D': 0%, 'E': 4.17%, 'F': 4.17%, 'G': 8.33%, 'H': 0%, 'I': 4.17%, 'K': 12.5%, 'L': 16.67%, AF 'M': 0%, 'N': 4.17%, 'P': 4.17%, 'Q': 8.33%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 4.17%, 'W': 4.17%, 'Y': 0% MA D, H, M, R, S, T, Y MO C; O LO A, E, F, I, N, P, V, W BA 12 LA 12 AA 1 BC 3 MC {'O': 5, 'J': 3} MF {'O': 0.15625, 'J': 0.09375} XX MM 3884.84 AI 109.688 II 21.5 HP 0.375 HM 0.348 IP 8.213 NC 1.689 SF 0.25, 0.125, 0.188 [Helix, Turn, Sheet] AR 0.063 ME 5500, 5750 MS 18.060387 XX SC beta XX TO MRSA 4 Clinical isolate (MIC = 2 μM) XX XR PubMed: 33427970 XR CAMP R4: CAMPSQ14322 SQ SEQUENCE 3884.84 DA MW 32AA WKJEJLCOPG CVOGALQOCF LQOLOCNCKI JK // ID AMRSAPFCS29 PN Peptide gamma 2 SO Synthetic construct PL 21 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 2, 'D': 0, 'E': 0, 'F': 0, 'G': 2, 'H': 0, 'I': 1, 'K': 5, 'L': 1, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 1, 'R': 4, 'S': 3, 'T': 1, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 9.52%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 9.52%, 'H': 0%, 'I': 4.76%, 'K': 23.81%, 'L': 4.76%, AF 'M': 0%, 'N': 0%, 'P': 4.76%, 'Q': 4.76%, 'R': 19.05%, 'S': 14.29%, 'T': 4.76%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, D, E, F, H, M, N, V, W, Y MO K LO I, L, P, Q, T BA 5 LA 16 AA 0 BC 9 MC 0 MF 0 XX MM 2417.923 AI 37.143 II 96.448 HP -1.581 HM 0.576 IP 12.142 NC 8.873 SF 0.095, 0.286, 0.048 [Helix, Turn, Sheet] AR 0 ME 0, 125 MS 54.181161 XX SC alpha XX TO MRSA strain 1 Clinical isolate (MIC = 1 μM) XX XR PubMed: 34818435 XR CAMP R4: CAMPSQ14375 SQ SEQUENCE 2417.923 DA MW 21AA CLPKRRQIGK SSTRGRKSCK K // ID AMRSAPFCS30 PN Peptide gamma 2 SO Synthetic construct PL 21 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 2, 'D': 0, 'E': 0, 'F': 0, 'G': 2, 'H': 0, 'I': 1, 'K': 5, 'L': 1, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 1, 'R': 4, 'S': 3, 'T': 1, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 9.52%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 9.52%, 'H': 0%, 'I': 4.76%, 'K': 23.81%, 'L': 4.76%, AF 'M': 0%, 'N': 0%, 'P': 4.76%, 'Q': 4.76%, 'R': 19.05%, 'S': 14.29%, 'T': 4.76%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, D, E, F, H, M, N, V, W, Y MO K LO I, L, P, Q, T BA 5 LA 16 AA 0 BC 9 MC 0 MF 0 XX MM 2417.923 AI 37.143 II 96.448 HP -1.581 HM 0.576 IP 12.142 NC 8.873 SF 0.095, 0.286, 0.048 [Helix, Turn, Sheet] AR 0 ME 0, 125 MS 54.181161 XX SC alpha XX TO MRSA strain 2 Clinical isolate (MIC = 2 μM) XX XR PubMed: 34818435 XR CAMP R4: CAMPSQ14375 SQ SEQUENCE 2417.923 DA MW 21AA CLPKRRQIGK SSTRGRKSCK K // ID AMRSAPFCS31 PN Peptide gamma 2 SO Synthetic construct PL 21 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 2, 'D': 0, 'E': 0, 'F': 0, 'G': 2, 'H': 0, 'I': 1, 'K': 5, 'L': 1, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 1, 'R': 4, 'S': 3, 'T': 1, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 9.52%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 9.52%, 'H': 0%, 'I': 4.76%, 'K': 23.81%, 'L': 4.76%, AF 'M': 0%, 'N': 0%, 'P': 4.76%, 'Q': 4.76%, 'R': 19.05%, 'S': 14.29%, 'T': 4.76%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, D, E, F, H, M, N, V, W, Y MO K LO I, L, P, Q, T BA 5 LA 16 AA 0 BC 9 MC 0 MF 0 XX MM 2417.923 AI 37.143 II 96.448 HP -1.581 HM 0.576 IP 12.142 NC 8.873 SF 0.095, 0.286, 0.048 [Helix, Turn, Sheet] AR 0 ME 0, 125 MS 54.181161 XX SC alpha XX TO MRSA strain 3 Clinical isolate (MIC = 2 μM) XX XR PubMed: 34818435 XR CAMP R4: CAMPSQ14375 SQ SEQUENCE 2417.923 DA MW 21AA CLPKRRQIGK SSTRGRKSCK K // ID AMRSAPFCS32 PN Endo88 SO Synthetic construct PL 481 TX Synthetic construct PE Experimentally validated XX AC 'A': 36, 'C': 6, 'D': 21, 'E': 24, 'F': 20, 'G': 45, 'H': 9, 'I': 23, 'K': 32, 'L': 33, AC 'M': 7, 'N': 27, 'P': 26, 'Q': 26, 'R': 19, 'S': 27, 'T': 28, 'V': 30, 'W': 17, 'Y': 25 AF 'A': 7.48%, 'C': 1.25%, 'D': 4.37%, 'E': 4.99%, 'F': 4.16%, 'G': 9.36%, 'H': 1.87%, 'I': 4.78%, 'K': 6.65%, 'L': 6.86%, AF 'M': 1.46%, 'N': 5.61%, 'P': 5.41%, 'Q': 5.41%, 'R': 3.95%, 'S': 5.61%, 'T': 5.82%, 'V': 6.24%, 'W': 3.53%, 'Y': 5.2% MA MO G LO C BA 237 LA 244 AA 45 BC 60 MC 0 MF 0 XX MM 54119.155 AI 70.977 II 39.166 HP -0.471 HM 0.777 IP 8.789 NC 6.466 SF 0.308, 0.26, 0.208 [Helix, Turn, Sheet] AR 0.129 ME 130750, 131125 MS 307.026579 XX SC alpha_beta XX TO Clinical isolates MRSA 6 XX XR PubMed: 35251775 XR CAMP R4: CAMPSQ15132 SQ SEQUENCE 54119.155 DA MW 481AA MQAKLTKKEF IEWLKTSEGK QFNVDLWYGF QCFDYANAGW KVLFGLLLKG LGAKDIPFAN NFDGLATVYQ NTPDFLAQPG DMVVFGSNYG AGYGHVAWVI EATLDYIIVY EQNWLGGGWT DRIEQPGWGW EKVTRRQHAY DFPMWFIRPN FKSETAPRSI QSPTQASKKE TAKPQPKAVE LKIIKDVVKG YDLPKRGGNP KGIVIHNDAG SKGATAEAYR NGLVNAPSSR LEAGIAHSYV SGNTVWQALD ESQVGWHTAN QLGNKYYYGI EVCQSMGADN ATFLKNEQAT FQECARLLKK WGLPANRNTI RLHNEFTSTS CPHRSSVLHT GFDPVTRGLL PEDKQLQLKD YFIKQIRVYM DGKIPVATVS NESSASSNTV KPVASAWKRN KYGTYYMEES ARFTNGNQPI TVRKIGPFLS CPVAYQFQPG GYCDYTEVML QDGHVWVGYT WEGQRYYLPI RTWNGSAPPN QILGDLWGEI S // ID AMRSAPFCS33 PN Endo88 SO Synthetic construct PL 481 TX Synthetic construct PE Experimentally validated XX AC 'A': 36, 'C': 6, 'D': 21, 'E': 24, 'F': 20, 'G': 45, 'H': 9, 'I': 23, 'K': 32, 'L': 33, AC 'M': 7, 'N': 27, 'P': 26, 'Q': 26, 'R': 19, 'S': 27, 'T': 28, 'V': 30, 'W': 17, 'Y': 25 AF 'A': 7.48%, 'C': 1.25%, 'D': 4.37%, 'E': 4.99%, 'F': 4.16%, 'G': 9.36%, 'H': 1.87%, 'I': 4.78%, 'K': 6.65%, 'L': 6.86%, AF 'M': 1.46%, 'N': 5.61%, 'P': 5.41%, 'Q': 5.41%, 'R': 3.95%, 'S': 5.61%, 'T': 5.82%, 'V': 6.24%, 'W': 3.53%, 'Y': 5.2% MA MO G LO C BA 237 LA 244 AA 45 BC 60 MC 0 MF 0 XX MM 54119.155 AI 70.977 II 39.166 HP -0.471 HM 0.777 IP 8.789 NC 6.466 SF 0.308, 0.26, 0.208 [Helix, Turn, Sheet] AR 0.129 ME 130750, 131125 MS 307.026579 XX SC alpha_beta XX TO Clinical isolates MRSA 7 XX XR PubMed: 35251775 XR CAMP R4: CAMPSQ15132 SQ SEQUENCE 54119.155 DA MW 481AA MQAKLTKKEF IEWLKTSEGK QFNVDLWYGF QCFDYANAGW KVLFGLLLKG LGAKDIPFAN NFDGLATVYQ NTPDFLAQPG DMVVFGSNYG AGYGHVAWVI EATLDYIIVY EQNWLGGGWT DRIEQPGWGW EKVTRRQHAY DFPMWFIRPN FKSETAPRSI QSPTQASKKE TAKPQPKAVE LKIIKDVVKG YDLPKRGGNP KGIVIHNDAG SKGATAEAYR NGLVNAPSSR LEAGIAHSYV SGNTVWQALD ESQVGWHTAN QLGNKYYYGI EVCQSMGADN ATFLKNEQAT FQECARLLKK WGLPANRNTI RLHNEFTSTS CPHRSSVLHT GFDPVTRGLL PEDKQLQLKD YFIKQIRVYM DGKIPVATVS NESSASSNTV KPVASAWKRN KYGTYYMEES ARFTNGNQPI TVRKIGPFLS CPVAYQFQPG GYCDYTEVML QDGHVWVGYT WEGQRYYLPI RTWNGSAPPN QILGDLWGEI S // ID AMRSAPFCS34 PN Endo88 SO Synthetic construct PL 481 TX Synthetic construct PE Experimentally validated XX AC 'A': 36, 'C': 6, 'D': 21, 'E': 24, 'F': 20, 'G': 45, 'H': 9, 'I': 23, 'K': 32, 'L': 33, AC 'M': 7, 'N': 27, 'P': 26, 'Q': 26, 'R': 19, 'S': 27, 'T': 28, 'V': 30, 'W': 17, 'Y': 25 AF 'A': 7.48%, 'C': 1.25%, 'D': 4.37%, 'E': 4.99%, 'F': 4.16%, 'G': 9.36%, 'H': 1.87%, 'I': 4.78%, 'K': 6.65%, 'L': 6.86%, AF 'M': 1.46%, 'N': 5.61%, 'P': 5.41%, 'Q': 5.41%, 'R': 3.95%, 'S': 5.61%, 'T': 5.82%, 'V': 6.24%, 'W': 3.53%, 'Y': 5.2% MA MO G LO C BA 237 LA 244 AA 45 BC 60 MC 0 MF 0 XX MM 54119.155 AI 70.977 II 39.166 HP -0.471 HM 0.777 IP 8.789 NC 6.466 SF 0.308, 0.26, 0.208 [Helix, Turn, Sheet] AR 0.129 ME 130750, 131125 MS 307.026579 XX SC alpha_beta XX TO Clinical isolates MRSA 8 XX XR PubMed: 35251775 XR CAMP R4: CAMPSQ15132 SQ SEQUENCE 54119.155 DA MW 481AA MQAKLTKKEF IEWLKTSEGK QFNVDLWYGF QCFDYANAGW KVLFGLLLKG LGAKDIPFAN NFDGLATVYQ NTPDFLAQPG DMVVFGSNYG AGYGHVAWVI EATLDYIIVY EQNWLGGGWT DRIEQPGWGW EKVTRRQHAY DFPMWFIRPN FKSETAPRSI QSPTQASKKE TAKPQPKAVE LKIIKDVVKG YDLPKRGGNP KGIVIHNDAG SKGATAEAYR NGLVNAPSSR LEAGIAHSYV SGNTVWQALD ESQVGWHTAN QLGNKYYYGI EVCQSMGADN ATFLKNEQAT FQECARLLKK WGLPANRNTI RLHNEFTSTS CPHRSSVLHT GFDPVTRGLL PEDKQLQLKD YFIKQIRVYM DGKIPVATVS NESSASSNTV KPVASAWKRN KYGTYYMEES ARFTNGNQPI TVRKIGPFLS CPVAYQFQPG GYCDYTEVML QDGHVWVGYT WEGQRYYLPI RTWNGSAPPN QILGDLWGEI S // ID AMRSAPFCS35 PN Endo88 SO Synthetic construct PL 481 TX Synthetic construct PE Experimentally validated XX AC 'A': 36, 'C': 6, 'D': 21, 'E': 24, 'F': 20, 'G': 45, 'H': 9, 'I': 23, 'K': 32, 'L': 33, AC 'M': 7, 'N': 27, 'P': 26, 'Q': 26, 'R': 19, 'S': 27, 'T': 28, 'V': 30, 'W': 17, 'Y': 25 AF 'A': 7.48%, 'C': 1.25%, 'D': 4.37%, 'E': 4.99%, 'F': 4.16%, 'G': 9.36%, 'H': 1.87%, 'I': 4.78%, 'K': 6.65%, 'L': 6.86%, AF 'M': 1.46%, 'N': 5.61%, 'P': 5.41%, 'Q': 5.41%, 'R': 3.95%, 'S': 5.61%, 'T': 5.82%, 'V': 6.24%, 'W': 3.53%, 'Y': 5.2% MA MO G LO C BA 237 LA 244 AA 45 BC 60 MC 0 MF 0 XX MM 54119.155 AI 70.977 II 39.166 HP -0.471 HM 0.777 IP 8.789 NC 6.466 SF 0.308, 0.26, 0.208 [Helix, Turn, Sheet] AR 0.129 ME 130750, 131125 MS 307.026579 XX SC alpha_beta XX TO Clinical isolates MRSA 10 XX XR PubMed: 35251775 XR CAMP R4: CAMPSQ15132 SQ SEQUENCE 54119.155 DA MW 481AA MQAKLTKKEF IEWLKTSEGK QFNVDLWYGF QCFDYANAGW KVLFGLLLKG LGAKDIPFAN NFDGLATVYQ NTPDFLAQPG DMVVFGSNYG AGYGHVAWVI EATLDYIIVY EQNWLGGGWT DRIEQPGWGW EKVTRRQHAY DFPMWFIRPN FKSETAPRSI QSPTQASKKE TAKPQPKAVE LKIIKDVVKG YDLPKRGGNP KGIVIHNDAG SKGATAEAYR NGLVNAPSSR LEAGIAHSYV SGNTVWQALD ESQVGWHTAN QLGNKYYYGI EVCQSMGADN ATFLKNEQAT FQECARLLKK WGLPANRNTI RLHNEFTSTS CPHRSSVLHT GFDPVTRGLL PEDKQLQLKD YFIKQIRVYM DGKIPVATVS NESSASSNTV KPVASAWKRN KYGTYYMEES ARFTNGNQPI TVRKIGPFLS CPVAYQFQPG GYCDYTEVML QDGHVWVGYT WEGQRYYLPI RTWNGSAPPN QILGDLWGEI S // ID AMRSAPFCS36 PN Endo88 SO Synthetic construct PL 481 TX Synthetic construct PE Experimentally validated XX AC 'A': 36, 'C': 6, 'D': 21, 'E': 24, 'F': 20, 'G': 45, 'H': 9, 'I': 23, 'K': 32, 'L': 33, AC 'M': 7, 'N': 27, 'P': 26, 'Q': 26, 'R': 19, 'S': 27, 'T': 28, 'V': 30, 'W': 17, 'Y': 25 AF 'A': 7.48%, 'C': 1.25%, 'D': 4.37%, 'E': 4.99%, 'F': 4.16%, 'G': 9.36%, 'H': 1.87%, 'I': 4.78%, 'K': 6.65%, 'L': 6.86%, AF 'M': 1.46%, 'N': 5.61%, 'P': 5.41%, 'Q': 5.41%, 'R': 3.95%, 'S': 5.61%, 'T': 5.82%, 'V': 6.24%, 'W': 3.53%, 'Y': 5.2% MA MO G LO C BA 237 LA 244 AA 45 BC 60 MC 0 MF 0 XX MM 54119.155 AI 70.977 II 39.166 HP -0.471 HM 0.777 IP 8.789 NC 6.466 SF 0.308, 0.26, 0.208 [Helix, Turn, Sheet] AR 0.129 ME 130750, 131125 MS 307.026579 XX SC alpha_beta XX TO Clinical isolates MRSA 12 XX XR PubMed: 35251775 XR CAMP R4: CAMPSQ15132 SQ SEQUENCE 54119.155 DA MW 481AA MQAKLTKKEF IEWLKTSEGK QFNVDLWYGF QCFDYANAGW KVLFGLLLKG LGAKDIPFAN NFDGLATVYQ NTPDFLAQPG DMVVFGSNYG AGYGHVAWVI EATLDYIIVY EQNWLGGGWT DRIEQPGWGW EKVTRRQHAY DFPMWFIRPN FKSETAPRSI QSPTQASKKE TAKPQPKAVE LKIIKDVVKG YDLPKRGGNP KGIVIHNDAG SKGATAEAYR NGLVNAPSSR LEAGIAHSYV SGNTVWQALD ESQVGWHTAN QLGNKYYYGI EVCQSMGADN ATFLKNEQAT FQECARLLKK WGLPANRNTI RLHNEFTSTS CPHRSSVLHT GFDPVTRGLL PEDKQLQLKD YFIKQIRVYM DGKIPVATVS NESSASSNTV KPVASAWKRN KYGTYYMEES ARFTNGNQPI TVRKIGPFLS CPVAYQFQPG GYCDYTEVML QDGHVWVGYT WEGQRYYLPI RTWNGSAPPN QILGDLWGEI S // ID AMRSAPFCS37 PN Endo88 SO Synthetic construct PL 481 TX Synthetic construct PE Experimentally validated XX AC 'A': 36, 'C': 6, 'D': 21, 'E': 24, 'F': 20, 'G': 45, 'H': 9, 'I': 23, 'K': 32, 'L': 33, AC 'M': 7, 'N': 27, 'P': 26, 'Q': 26, 'R': 19, 'S': 27, 'T': 28, 'V': 30, 'W': 17, 'Y': 25 AF 'A': 7.48%, 'C': 1.25%, 'D': 4.37%, 'E': 4.99%, 'F': 4.16%, 'G': 9.36%, 'H': 1.87%, 'I': 4.78%, 'K': 6.65%, 'L': 6.86%, AF 'M': 1.46%, 'N': 5.61%, 'P': 5.41%, 'Q': 5.41%, 'R': 3.95%, 'S': 5.61%, 'T': 5.82%, 'V': 6.24%, 'W': 3.53%, 'Y': 5.2% MA MO G LO C BA 237 LA 244 AA 45 BC 60 MC 0 MF 0 XX MM 54119.155 AI 70.977 II 39.166 HP -0.471 HM 0.777 IP 8.789 NC 6.466 SF 0.308, 0.26, 0.208 [Helix, Turn, Sheet] AR 0.129 ME 130750, 131125 MS 307.026579 XX SC alpha_beta XX TO Clinical isolates MRSA 20 XX XR PubMed: 35251775 XR CAMP R4: CAMPSQ15132 SQ SEQUENCE 54119.155 DA MW 481AA MQAKLTKKEF IEWLKTSEGK QFNVDLWYGF QCFDYANAGW KVLFGLLLKG LGAKDIPFAN NFDGLATVYQ NTPDFLAQPG DMVVFGSNYG AGYGHVAWVI EATLDYIIVY EQNWLGGGWT DRIEQPGWGW EKVTRRQHAY DFPMWFIRPN FKSETAPRSI QSPTQASKKE TAKPQPKAVE LKIIKDVVKG YDLPKRGGNP KGIVIHNDAG SKGATAEAYR NGLVNAPSSR LEAGIAHSYV SGNTVWQALD ESQVGWHTAN QLGNKYYYGI EVCQSMGADN ATFLKNEQAT FQECARLLKK WGLPANRNTI RLHNEFTSTS CPHRSSVLHT GFDPVTRGLL PEDKQLQLKD YFIKQIRVYM DGKIPVATVS NESSASSNTV KPVASAWKRN KYGTYYMEES ARFTNGNQPI TVRKIGPFLS CPVAYQFQPG GYCDYTEVML QDGHVWVGYT WEGQRYYLPI RTWNGSAPPN QILGDLWGEI S // ID AMRSAPFCS38 PN Endo88 SO Synthetic construct PL 481 TX Synthetic construct PE Experimentally validated XX AC 'A': 36, 'C': 6, 'D': 21, 'E': 24, 'F': 20, 'G': 45, 'H': 9, 'I': 23, 'K': 32, 'L': 33, AC 'M': 7, 'N': 27, 'P': 26, 'Q': 26, 'R': 19, 'S': 27, 'T': 28, 'V': 30, 'W': 17, 'Y': 25 AF 'A': 7.48%, 'C': 1.25%, 'D': 4.37%, 'E': 4.99%, 'F': 4.16%, 'G': 9.36%, 'H': 1.87%, 'I': 4.78%, 'K': 6.65%, 'L': 6.86%, AF 'M': 1.46%, 'N': 5.61%, 'P': 5.41%, 'Q': 5.41%, 'R': 3.95%, 'S': 5.61%, 'T': 5.82%, 'V': 6.24%, 'W': 3.53%, 'Y': 5.2% MA MO G LO C BA 237 LA 244 AA 45 BC 60 MC 0 MF 0 XX MM 54119.155 AI 70.977 II 39.166 HP -0.471 HM 0.777 IP 8.789 NC 6.466 SF 0.308, 0.26, 0.208 [Helix, Turn, Sheet] AR 0.129 ME 130750, 131125 MS 307.026579 XX SC alpha_beta XX TO Clinical isolates MRSA 22 XX XR PubMed: 35251775 XR CAMP R4: CAMPSQ15132 SQ SEQUENCE 54119.155 DA MW 481AA MQAKLTKKEF IEWLKTSEGK QFNVDLWYGF QCFDYANAGW KVLFGLLLKG LGAKDIPFAN NFDGLATVYQ NTPDFLAQPG DMVVFGSNYG AGYGHVAWVI EATLDYIIVY EQNWLGGGWT DRIEQPGWGW EKVTRRQHAY DFPMWFIRPN FKSETAPRSI QSPTQASKKE TAKPQPKAVE LKIIKDVVKG YDLPKRGGNP KGIVIHNDAG SKGATAEAYR NGLVNAPSSR LEAGIAHSYV SGNTVWQALD ESQVGWHTAN QLGNKYYYGI EVCQSMGADN ATFLKNEQAT FQECARLLKK WGLPANRNTI RLHNEFTSTS CPHRSSVLHT GFDPVTRGLL PEDKQLQLKD YFIKQIRVYM DGKIPVATVS NESSASSNTV KPVASAWKRN KYGTYYMEES ARFTNGNQPI TVRKIGPFLS CPVAYQFQPG GYCDYTEVML QDGHVWVGYT WEGQRYYLPI RTWNGSAPPN QILGDLWGEI S // ID AMRSAPFCS39 PN WLBU2 SO Synthetic construct PL 24 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 13, 'S': 0, 'T': 0, 'V': 8, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 54.17%, 'S': 0%, 'T': 0%, 'V': 33.33%, 'W': 12.5%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, Y MO R LO W BA 11 LA 13 AA 0 BC 13 MC 0 MF 0 XX MM 3400.153 AI 96.667 II 213.771 HP -1.15 HM 1.185 IP 13.579 NC 12.998 SF 0.458, 0, 0 [Helix, Turn, Sheet] AR 0.125 ME 16500, 16500 MS 78.261677 XX SC beta XX TO MRSA Clinical isolate 1 (MIC = 6.25 μM) XX XR PubMed: 34907712 XR CAMP R4: CAMPSQ3388 SQ SEQUENCE 3400.153 DA MW 24AA RRWVRRVRRW VRRVVRVVRR WVRR // ID AMRSAPFCS40 PN WLBU2 SO Synthetic construct PL 24 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 13, 'S': 0, 'T': 0, 'V': 8, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 54.17%, 'S': 0%, 'T': 0%, 'V': 33.33%, 'W': 12.5%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, Y MO R LO W BA 11 LA 13 AA 0 BC 13 MC 0 MF 0 XX MM 3400.153 AI 96.667 II 213.771 HP -1.15 HM 1.185 IP 13.579 NC 12.998 SF 0.458, 0, 0 [Helix, Turn, Sheet] AR 0.125 ME 16500, 16500 MS 78.261677 XX SC beta XX TO MRSA Clinical isolate 2 (MIC = 3.13 μM) XX XR PubMed: 34907712 XR CAMP R4: CAMPSQ3388 SQ SEQUENCE 3400.153 DA MW 24AA RRWVRRVRRW VRRVVRVVRR WVRR // ID AMRSAPFCS41 PN WLBU2 SO Synthetic construct PL 24 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 13, 'S': 0, 'T': 0, 'V': 8, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 54.17%, 'S': 0%, 'T': 0%, 'V': 33.33%, 'W': 12.5%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, Y MO R LO W BA 11 LA 13 AA 0 BC 13 MC 0 MF 0 XX MM 3400.153 AI 96.667 II 213.771 HP -1.15 HM 1.185 IP 13.579 NC 12.998 SF 0.458, 0, 0 [Helix, Turn, Sheet] AR 0.125 ME 16500, 16500 MS 78.261677 XX SC beta XX TO MRSA Clinical isolate 3 (MIC = 1.56 μM) XX XR PubMed: 34907712 XR CAMP R4: CAMPSQ3388 SQ SEQUENCE 3400.153 DA MW 24AA RRWVRRVRRW VRRVVRVVRR WVRR // ID AMRSAPFCS42 PN WLBU2 SO Synthetic construct PL 24 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 13, 'S': 0, 'T': 0, 'V': 8, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 54.17%, 'S': 0%, 'T': 0%, 'V': 33.33%, 'W': 12.5%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, Y MO R LO W BA 11 LA 13 AA 0 BC 13 MC 0 MF 0 XX MM 3400.153 AI 96.667 II 213.771 HP -1.15 HM 1.185 IP 13.579 NC 12.998 SF 0.458, 0, 0 [Helix, Turn, Sheet] AR 0.125 ME 16500, 16500 MS 78.261677 XX SC beta XX TO MRSA Clinical isolate 4 (MIC = 0.78 μM) XX XR PubMed: 34907712 XR CAMP R4: CAMPSQ3388 SQ SEQUENCE 3400.153 DA MW 24AA RRWVRRVRRW VRRVVRVVRR WVRR // ID AMRSAPFCS43 PN WLBU2 SO Synthetic construct PL 24 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 13, 'S': 0, 'T': 0, 'V': 8, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 54.17%, 'S': 0%, 'T': 0%, 'V': 33.33%, 'W': 12.5%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, Y MO R LO W BA 11 LA 13 AA 0 BC 13 MC 0 MF 0 XX MM 3400.153 AI 96.667 II 213.771 HP -1.15 HM 1.185 IP 13.579 NC 12.998 SF 0.458, 0, 0 [Helix, Turn, Sheet] AR 0.125 ME 16500, 16500 MS 78.261677 XX SC beta XX TO MRSA Clinical isolate 5 (MIC = 6.25 μM) XX XR PubMed: 34907712 XR CAMP R4: CAMPSQ3388 SQ SEQUENCE 3400.153 DA MW 24AA RRWVRRVRRW VRRVVRVVRR WVRR // ID AMRSAPFCS44 PN WLBU2 SO Synthetic construct PL 24 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 13, 'S': 0, 'T': 0, 'V': 8, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 54.17%, 'S': 0%, 'T': 0%, 'V': 33.33%, 'W': 12.5%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, Y MO R LO W BA 11 LA 13 AA 0 BC 13 MC 0 MF 0 XX MM 3400.153 AI 96.667 II 213.771 HP -1.15 HM 1.185 IP 13.579 NC 12.998 SF 0.458, 0, 0 [Helix, Turn, Sheet] AR 0.125 ME 16500, 16500 MS 78.261677 XX SC beta XX TO MRSA Clinical isolate 6 (MIC = 6.25 μM) XX XR PubMed: 34907712 XR CAMP R4: CAMPSQ3388 SQ SEQUENCE 3400.153 DA MW 24AA RRWVRRVRRW VRRVVRVVRR WVRR // ID AMRSAPFCS45 PN WLBU2 SO Synthetic construct PL 24 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 13, 'S': 0, 'T': 0, 'V': 8, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 54.17%, 'S': 0%, 'T': 0%, 'V': 33.33%, 'W': 12.5%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, Y MO R LO W BA 11 LA 13 AA 0 BC 13 MC 0 MF 0 XX MM 3400.153 AI 96.667 II 213.771 HP -1.15 HM 1.185 IP 13.579 NC 12.998 SF 0.458, 0, 0 [Helix, Turn, Sheet] AR 0.125 ME 16500, 16500 MS 78.261677 XX SC beta XX TO MRSA Clinical isolate 7 (MIC = 1.56 μM) XX XR PubMed: 34907712 XR CAMP R4: CAMPSQ3388 SQ SEQUENCE 3400.153 DA MW 24AA RRWVRRVRRW VRRVVRVVRR WVRR // ID AMRSAPFCS46 PN WLBU2 SO Synthetic construct PL 24 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 13, 'S': 0, 'T': 0, 'V': 8, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 54.17%, 'S': 0%, 'T': 0%, 'V': 33.33%, 'W': 12.5%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, Y MO R LO W BA 11 LA 13 AA 0 BC 13 MC 0 MF 0 XX MM 3400.153 AI 96.667 II 213.771 HP -1.15 HM 1.185 IP 13.579 NC 12.998 SF 0.458, 0, 0 [Helix, Turn, Sheet] AR 0.125 ME 16500, 16500 MS 78.261677 XX SC beta XX TO MRSA Clinical isolate 8 (MIC = 3.13 μM) XX XR PubMed: 34907712 XR CAMP R4: CAMPSQ3388 SQ SEQUENCE 3400.153 DA MW 24AA RRWVRRVRRW VRRVVRVVRR WVRR // ID AMRSAPFCS47 PN WLBU2 SO Synthetic construct PL 24 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 13, 'S': 0, 'T': 0, 'V': 8, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 54.17%, 'S': 0%, 'T': 0%, 'V': 33.33%, 'W': 12.5%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, Y MO R LO W BA 11 LA 13 AA 0 BC 13 MC 0 MF 0 XX MM 3400.153 AI 96.667 II 213.771 HP -1.15 HM 1.185 IP 13.579 NC 12.998 SF 0.458, 0, 0 [Helix, Turn, Sheet] AR 0.125 ME 16500, 16500 MS 78.261677 XX SC beta XX TO MRSA Clinical isolate 9 (MIC = 3.13 μM) XX XR PubMed: 34907712 XR CAMP R4: CAMPSQ3388 SQ SEQUENCE 3400.153 DA MW 24AA RRWVRRVRRW VRRVVRVVRR WVRR // ID AMRSAPFCS48 PN WLBU2 SO Synthetic construct PL 24 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 13, 'S': 0, 'T': 0, 'V': 8, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 54.17%, 'S': 0%, 'T': 0%, 'V': 33.33%, 'W': 12.5%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, Y MO R LO W BA 11 LA 13 AA 0 BC 13 MC 0 MF 0 XX MM 3400.153 AI 96.667 II 213.771 HP -1.15 HM 1.185 IP 13.579 NC 12.998 SF 0.458, 0, 0 [Helix, Turn, Sheet] AR 0.125 ME 16500, 16500 MS 78.261677 XX SC beta XX TO MRSA Clinical isolate 10 (MIC = 3.13 μM) XX XR PubMed: 34907712 XR CAMP R4: CAMPSQ3388 SQ SEQUENCE 3400.153 DA MW 24AA RRWVRRVRRW VRRVVRVVRR WVRR // ID AMRSAPFCS49 PN WLBU2 SO Synthetic construct PL 24 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 13, 'S': 0, 'T': 0, 'V': 8, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 54.17%, 'S': 0%, 'T': 0%, 'V': 33.33%, 'W': 12.5%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, Y MO R LO W BA 11 LA 13 AA 0 BC 13 MC 0 MF 0 XX MM 3400.153 AI 96.667 II 213.771 HP -1.15 HM 1.185 IP 13.579 NC 12.998 SF 0.458, 0, 0 [Helix, Turn, Sheet] AR 0.125 ME 16500, 16500 MS 78.261677 XX SC beta XX TO MRSA Clinical isolate 11 (MIC = 1.56 μM) XX XR PubMed: 34907712 XR CAMP R4: CAMPSQ3388 SQ SEQUENCE 3400.153 DA MW 24AA RRWVRRVRRW VRRVVRVVRR WVRR // ID AMRSAPFCS50 PN WLBU2 SO Synthetic construct PL 24 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 13, 'S': 0, 'T': 0, 'V': 8, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 54.17%, 'S': 0%, 'T': 0%, 'V': 33.33%, 'W': 12.5%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, Y MO R LO W BA 11 LA 13 AA 0 BC 13 MC 0 MF 0 XX MM 3400.153 AI 96.667 II 213.771 HP -1.15 HM 1.185 IP 13.579 NC 12.998 SF 0.458, 0, 0 [Helix, Turn, Sheet] AR 0.125 ME 16500, 16500 MS 78.261677 XX SC beta XX TO MRSA Clinical isolate 12 (MIC = 3.13 μM) XX XR PubMed: 34907712 XR CAMP R4: CAMPSQ3388 SQ SEQUENCE 3400.153 DA MW 24AA RRWVRRVRRW VRRVVRVVRR WVRR // ID AMRSAPFCS51 PN WLBU2 SO Synthetic construct PL 24 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 13, 'S': 0, 'T': 0, 'V': 8, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 54.17%, 'S': 0%, 'T': 0%, 'V': 33.33%, 'W': 12.5%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, Y MO R LO W BA 11 LA 13 AA 0 BC 13 MC 0 MF 0 XX MM 3400.153 AI 96.667 II 213.771 HP -1.15 HM 1.185 IP 13.579 NC 12.998 SF 0.458, 0, 0 [Helix, Turn, Sheet] AR 0.125 ME 16500, 16500 MS 78.261677 XX SC beta XX TO MRSA Clinical isolate 13 (MIC = 1.56 μM) XX XR PubMed: 34907712 XR CAMP R4: CAMPSQ3388 SQ SEQUENCE 3400.153 DA MW 24AA RRWVRRVRRW VRRVVRVVRR WVRR // ID AMRSAPFCS52 PN WLBU2 SO Synthetic construct PL 24 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 13, 'S': 0, 'T': 0, 'V': 8, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 54.17%, 'S': 0%, 'T': 0%, 'V': 33.33%, 'W': 12.5%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, Y MO R LO W BA 11 LA 13 AA 0 BC 13 MC 0 MF 0 XX MM 3400.153 AI 96.667 II 213.771 HP -1.15 HM 1.185 IP 13.579 NC 12.998 SF 0.458, 0, 0 [Helix, Turn, Sheet] AR 0.125 ME 16500, 16500 MS 78.261677 XX SC beta XX TO MRSA Clinical isolate 14 (MIC = 3.13 μM) XX XR PubMed: 34907712 XR CAMP R4: CAMPSQ3388 SQ SEQUENCE 3400.153 DA MW 24AA RRWVRRVRRW VRRVVRVVRR WVRR // ID AMRSAPFCS53 PN WLBU2 SO Synthetic construct PL 24 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 13, 'S': 0, 'T': 0, 'V': 8, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 54.17%, 'S': 0%, 'T': 0%, 'V': 33.33%, 'W': 12.5%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, Y MO R LO W BA 11 LA 13 AA 0 BC 13 MC 0 MF 0 XX MM 3400.153 AI 96.667 II 213.771 HP -1.15 HM 1.185 IP 13.579 NC 12.998 SF 0.458, 0, 0 [Helix, Turn, Sheet] AR 0.125 ME 16500, 16500 MS 78.261677 XX SC beta XX TO MRSA Clinical isolate 15 (MIC = 3.13 μM) XX XR PubMed: 34907712 XR CAMP R4: CAMPSQ3388 SQ SEQUENCE 3400.153 DA MW 24AA RRWVRRVRRW VRRVVRVVRR WVRR // ID AMRSAPFCS54 PN WLBU2 SO Synthetic construct PL 24 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 13, 'S': 0, 'T': 0, 'V': 8, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 54.17%, 'S': 0%, 'T': 0%, 'V': 33.33%, 'W': 12.5%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, Y MO R LO W BA 11 LA 13 AA 0 BC 13 MC 0 MF 0 XX MM 3400.153 AI 96.667 II 213.771 HP -1.15 HM 1.185 IP 13.579 NC 12.998 SF 0.458, 0, 0 [Helix, Turn, Sheet] AR 0.125 ME 16500, 16500 MS 78.261677 XX SC beta XX TO MRSA Clinical isolate 16 (MIC = 3.13 μM) XX XR PubMed: 34907712 XR CAMP R4: CAMPSQ3388 SQ SEQUENCE 3400.153 DA MW 24AA RRWVRRVRRW VRRVVRVVRR WVRR // ID AMRSAPFCS55 PN WLBU2 SO Synthetic construct PL 24 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 13, 'S': 0, 'T': 0, 'V': 8, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 54.17%, 'S': 0%, 'T': 0%, 'V': 33.33%, 'W': 12.5%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, Y MO R LO W BA 11 LA 13 AA 0 BC 13 MC 0 MF 0 XX MM 3400.153 AI 96.667 II 213.771 HP -1.15 HM 1.185 IP 13.579 NC 12.998 SF 0.458, 0, 0 [Helix, Turn, Sheet] AR 0.125 ME 16500, 16500 MS 78.261677 XX SC beta XX TO MRSA Clinical isolate 17 (MIC = 3.13 μM) XX XR PubMed: 34907712 XR CAMP R4: CAMPSQ3388 SQ SEQUENCE 3400.153 DA MW 24AA RRWVRRVRRW VRRVVRVVRR WVRR // ID AMRSAPFCS56 PN WLBU2 SO Synthetic construct PL 24 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 13, 'S': 0, 'T': 0, 'V': 8, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 54.17%, 'S': 0%, 'T': 0%, 'V': 33.33%, 'W': 12.5%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, Y MO R LO W BA 11 LA 13 AA 0 BC 13 MC 0 MF 0 XX MM 3400.153 AI 96.667 II 213.771 HP -1.15 HM 1.185 IP 13.579 NC 12.998 SF 0.458, 0, 0 [Helix, Turn, Sheet] AR 0.125 ME 16500, 16500 MS 78.261677 XX SC beta XX TO MRSA Clinical isolate 18 (MIC = 3.13 μM) XX XR PubMed: 34907712 XR CAMP R4: CAMPSQ3388 SQ SEQUENCE 3400.153 DA MW 24AA RRWVRRVRRW VRRVVRVVRR WVRR // ID AMRSAPFCS57 PN WLBU2 SO Synthetic construct PL 24 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 13, 'S': 0, 'T': 0, 'V': 8, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 54.17%, 'S': 0%, 'T': 0%, 'V': 33.33%, 'W': 12.5%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, Y MO R LO W BA 11 LA 13 AA 0 BC 13 MC 0 MF 0 XX MM 3400.153 AI 96.667 II 213.771 HP -1.15 HM 1.185 IP 13.579 NC 12.998 SF 0.458, 0, 0 [Helix, Turn, Sheet] AR 0.125 ME 16500, 16500 MS 78.261677 XX SC beta XX TO MRSA Clinical isolate 19 (MIC = 3.13 μM) XX XR PubMed: 34907712 XR CAMP R4: CAMPSQ3388 SQ SEQUENCE 3400.153 DA MW 24AA RRWVRRVRRW VRRVVRVVRR WVRR // ID AMRSAPFCS58 PN WLBU2 SO Synthetic construct PL 24 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 13, 'S': 0, 'T': 0, 'V': 8, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 54.17%, 'S': 0%, 'T': 0%, 'V': 33.33%, 'W': 12.5%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, Y MO R LO W BA 11 LA 13 AA 0 BC 13 MC 0 MF 0 XX MM 3400.153 AI 96.667 II 213.771 HP -1.15 HM 1.185 IP 13.579 NC 12.998 SF 0.458, 0, 0 [Helix, Turn, Sheet] AR 0.125 ME 16500, 16500 MS 78.261677 XX SC beta XX TO MRSA Clinical isolate 20 (MIC = 6.25 μM) XX XR PubMed: 34907712 XR CAMP R4: CAMPSQ3388 SQ SEQUENCE 3400.153 DA MW 24AA RRWVRRVRRW VRRVVRVVRR WVRR // ID AMRSAPFCS59 PN WLBU2 SO Synthetic construct PL 24 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 13, 'S': 0, 'T': 0, 'V': 8, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 54.17%, 'S': 0%, 'T': 0%, 'V': 33.33%, 'W': 12.5%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, Y MO R LO W BA 11 LA 13 AA 0 BC 13 MC 0 MF 0 XX MM 3400.153 AI 96.667 II 213.771 HP -1.15 HM 1.185 IP 13.579 NC 12.998 SF 0.458, 0, 0 [Helix, Turn, Sheet] AR 0.125 ME 16500, 16500 MS 78.261677 XX SC beta XX TO MRSA Clinical isolate 21 (MIC = 6.25 μM) XX XR PubMed: 34907712 XR CAMP R4: CAMPSQ3388 SQ SEQUENCE 3400.153 DA MW 24AA RRWVRRVRRW VRRVVRVVRR WVRR // ID AMRSAPFCS60 PN WLBU2 SO Synthetic construct PL 24 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 13, 'S': 0, 'T': 0, 'V': 8, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 54.17%, 'S': 0%, 'T': 0%, 'V': 33.33%, 'W': 12.5%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, Y MO R LO W BA 11 LA 13 AA 0 BC 13 MC 0 MF 0 XX MM 3400.153 AI 96.667 II 213.771 HP -1.15 HM 1.185 IP 13.579 NC 12.998 SF 0.458, 0, 0 [Helix, Turn, Sheet] AR 0.125 ME 16500, 16500 MS 78.261677 XX SC beta XX TO MRSA Clinical isolate 22 (MIC = 1.56 μM) XX XR PubMed: 34907712 XR CAMP R4: CAMPSQ3388 SQ SEQUENCE 3400.153 DA MW 24AA RRWVRRVRRW VRRVVRVVRR WVRR // ID AMRSAPFCS61 PN WLBU2 SO Synthetic construct PL 24 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 13, 'S': 0, 'T': 0, 'V': 8, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 54.17%, 'S': 0%, 'T': 0%, 'V': 33.33%, 'W': 12.5%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, Y MO R LO W BA 11 LA 13 AA 0 BC 13 MC 0 MF 0 XX MM 3400.153 AI 96.667 II 213.771 HP -1.15 HM 1.185 IP 13.579 NC 12.998 SF 0.458, 0, 0 [Helix, Turn, Sheet] AR 0.125 ME 16500, 16500 MS 78.261677 XX SC beta XX TO MRSA Clinical isolate 23 (MIC = 1.56 μM) XX XR PubMed: 34907712 XR CAMP R4: CAMPSQ3388 SQ SEQUENCE 3400.153 DA MW 24AA RRWVRRVRRW VRRVVRVVRR WVRR // ID AMRSAPFCS62 PN WLBU2 SO Synthetic construct PL 24 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 13, 'S': 0, 'T': 0, 'V': 8, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 54.17%, 'S': 0%, 'T': 0%, 'V': 33.33%, 'W': 12.5%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, Y MO R LO W BA 11 LA 13 AA 0 BC 13 MC 0 MF 0 XX MM 3400.153 AI 96.667 II 213.771 HP -1.15 HM 1.185 IP 13.579 NC 12.998 SF 0.458, 0, 0 [Helix, Turn, Sheet] AR 0.125 ME 16500, 16500 MS 78.261677 XX SC beta XX TO MRSA Clinical isolate 24 (MIC = 1.56 μM) XX XR PubMed: 34907712 XR CAMP R4: CAMPSQ3388 SQ SEQUENCE 3400.153 DA MW 24AA RRWVRRVRRW VRRVVRVVRR WVRR // ID AMRSAPFCS63 PN WLBU2 SO Synthetic construct PL 24 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 13, 'S': 0, 'T': 0, 'V': 8, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 54.17%, 'S': 0%, 'T': 0%, 'V': 33.33%, 'W': 12.5%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, Y MO R LO W BA 11 LA 13 AA 0 BC 13 MC 0 MF 0 XX MM 3400.153 AI 96.667 II 213.771 HP -1.15 HM 1.185 IP 13.579 NC 12.998 SF 0.458, 0, 0 [Helix, Turn, Sheet] AR 0.125 ME 16500, 16500 MS 78.261677 XX SC beta XX TO MRSA Clinical isolate 25 (MIC = 3.13 μM) XX XR PubMed: 34907712 XR CAMP R4: CAMPSQ3388 SQ SEQUENCE 3400.153 DA MW 24AA RRWVRRVRRW VRRVVRVVRR WVRR // ID AMRSAPFCS64 PN WLBU2 SO Synthetic construct PL 24 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 13, 'S': 0, 'T': 0, 'V': 8, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 54.17%, 'S': 0%, 'T': 0%, 'V': 33.33%, 'W': 12.5%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, Y MO R LO W BA 11 LA 13 AA 0 BC 13 MC 0 MF 0 XX MM 3400.153 AI 96.667 II 213.771 HP -1.15 HM 1.185 IP 13.579 NC 12.998 SF 0.458, 0, 0 [Helix, Turn, Sheet] AR 0.125 ME 16500, 16500 MS 78.261677 XX SC beta XX TO MRSA Clinical isolate 26 (MIC = 6.25 μM) XX XR PubMed: 34907712 XR CAMP R4: CAMPSQ3388 SQ SEQUENCE 3400.153 DA MW 24AA RRWVRRVRRW VRRVVRVVRR WVRR // ID AMRSAPFCS65 PN WLBU2 SO Synthetic construct PL 24 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 13, 'S': 0, 'T': 0, 'V': 8, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 54.17%, 'S': 0%, 'T': 0%, 'V': 33.33%, 'W': 12.5%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, Y MO R LO W BA 11 LA 13 AA 0 BC 13 MC 0 MF 0 XX MM 3400.153 AI 96.667 II 213.771 HP -1.15 HM 1.185 IP 13.579 NC 12.998 SF 0.458, 0, 0 [Helix, Turn, Sheet] AR 0.125 ME 16500, 16500 MS 78.261677 XX SC beta XX TO MRSA Clinical isolate 27 (MIC = 6.25 μM) XX XR PubMed: 34907712 XR CAMP R4: CAMPSQ3388 SQ SEQUENCE 3400.153 DA MW 24AA RRWVRRVRRW VRRVVRVVRR WVRR // ID AMRSAPFCS66 PN WLBU2 SO Synthetic construct PL 24 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 13, 'S': 0, 'T': 0, 'V': 8, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 54.17%, 'S': 0%, 'T': 0%, 'V': 33.33%, 'W': 12.5%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, Y MO R LO W BA 11 LA 13 AA 0 BC 13 MC 0 MF 0 XX MM 3400.153 AI 96.667 II 213.771 HP -1.15 HM 1.185 IP 13.579 NC 12.998 SF 0.458, 0, 0 [Helix, Turn, Sheet] AR 0.125 ME 16500, 16500 MS 78.261677 XX SC beta XX TO MRSA Clinical isolate 28 (MIC = 3.13 μM) XX XR PubMed: 34907712 XR CAMP R4: CAMPSQ3388 SQ SEQUENCE 3400.153 DA MW 24AA RRWVRRVRRW VRRVVRVVRR WVRR // ID AMRSAPFCS67 PN WLBU2 SO Synthetic construct PL 24 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 13, 'S': 0, 'T': 0, 'V': 8, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 54.17%, 'S': 0%, 'T': 0%, 'V': 33.33%, 'W': 12.5%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, Y MO R LO W BA 11 LA 13 AA 0 BC 13 MC 0 MF 0 XX MM 3400.153 AI 96.667 II 213.771 HP -1.15 HM 1.185 IP 13.579 NC 12.998 SF 0.458, 0, 0 [Helix, Turn, Sheet] AR 0.125 ME 16500, 16500 MS 78.261677 XX SC beta XX TO MRSA Clinical isolate 29 (MIC = 3.13 μM) XX XR PubMed: 34907712 XR CAMP R4: CAMPSQ3388 SQ SEQUENCE 3400.153 DA MW 24AA RRWVRRVRRW VRRVVRVVRR WVRR // ID AMRSAPFCS68 PN WLBU2 SO Synthetic construct PL 24 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 13, 'S': 0, 'T': 0, 'V': 8, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 54.17%, 'S': 0%, 'T': 0%, 'V': 33.33%, 'W': 12.5%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, Y MO R LO W BA 11 LA 13 AA 0 BC 13 MC 0 MF 0 XX MM 3400.153 AI 96.667 II 213.771 HP -1.15 HM 1.185 IP 13.579 NC 12.998 SF 0.458, 0, 0 [Helix, Turn, Sheet] AR 0.125 ME 16500, 16500 MS 78.261677 XX SC beta XX TO MRSA Clinical isolate 30 (MIC = 1.56 μM) XX XR PubMed: 34907712 XR CAMP R4: CAMPSQ3388 SQ SEQUENCE 3400.153 DA MW 24AA RRWVRRVRRW VRRVVRVVRR WVRR // ID AMRSAPFCS69 PN Mastoparan-L SO �Vespula lewisii PL 14 TX Animalia PE Experimentally validated XX AC 'A': 4, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 2, 'K': 3, 'L': 4, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 28.57%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 14.29%, 'K': 21.43%, 'L': 28.57%, AF 'M': 0%, 'N': 7.14%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, M, P, Q, R, S, T, V, W, Y MO A; L LO N BA 10 LA 4 AA 0 BC 3 MC 0 MF 0 XX MM 1479.913 AI 195.714 II 10.914 HP 1.157 HM 0.584 IP 11.103 NC 2.997 SF 0.429, 0.071, 0.571 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 18.060387 XX SC beta XX TO MRSA (clinical isolate 713623) (MIC >= 32 μM) XX XR PubMed: 31411881 XR CAMP R4: CAMPSQ9945 SQ SEQUENCE 1479.913 DA MW 14AA INLKALAALA KKIL // ID AMRSAPFCS70 PN Mastoparan-R1 SO Synthetic construct PL 14 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 3, 'K': 5, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 14.29%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 21.43%, 'K': 35.71%, 'L': 21.43%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 7.14%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, M, N, P, Q, S, T, V, W, Y MO K LO R BA 8 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 1636.187 AI 181.429 II 29.764 HP 0.321 HM 0.748 IP 12.055 NC 5.997 SF 0.429, 0, 0.357 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA (clinical isolate 713623) (MIC >= 32 μM) XX XR PubMed: 31411881 XR CAMP R4: CAMPSQ9946 SQ SEQUENCE 1636.187 DA MW 14AA KILKRLAAKI KKIL // ID AMRSAPFCS71 PN Mastoparan-R4 SO Synthetic construct PL 14 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 3, 'K': 5, 'L': 2, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 14.29%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 21.43%, 'K': 35.71%, 'L': 14.29%, AF 'M': 0%, 'N': 7.14%, 'P': 0%, 'Q': 0%, 'R': 7.14%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, M, P, Q, S, T, V, W, Y MO K LO N, R BA 7 LA 7 AA 0 BC 6 MC 0 MF 0 XX MM 1637.132 AI 153.571 II -14.971 HP -0.2 HM 0.654 IP 12.055 NC 5.997 SF 0.357, 0.071, 0.286 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA (clinical isolate 713623) (MIC= 8 μM) XX XR PubMed: 31411881 XR CAMP R4: CAMPSQ9950 SQ SEQUENCE 1637.132 DA MW 14AA INLKKLAARI KKKI // ID AMRSAPFCS72 PN Pleurocidins SO Winter flounder PL 25 TX Animalia (Pisces) PE Experimentally validated XX AC 'A': 4, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 4, 'H': 3, 'I': 0, 'K': 4, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 1, 'T': 1, 'V': 2, 'W': 1, 'Y': 1 AF 'A': 16%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 8%, 'G': 16%, 'H': 12%, 'I': 0%, 'K': 16%, 'L': 8%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 4%, 'T': 4%, 'V': 8%, 'W': 4%, 'Y': 4% MA C, D, E, I, M, N, P, Q, R MO A; G; K LO S, T, W, Y BA 15 LA 10 AA 0 BC 7 MC 0 MF 0 XX MM 2711.167 AI 70.4 II 4.972 HP -0.068 HM 0.593 IP 10.866 NC 4.269 SF 0.32, 0.2, 0.24 [Helix, Turn, Sheet] AR 0.16 ME 6990, 6990 MS 24.080516 XX SC alpha XX TO Staphylococcus aureus Methicillin resistant clinical isolate (MIC = 8 μG/mL) XX XR PubMed: 12950255 XR CAMP R4: NA SQ SEQUENCE 2711.167 DA MW 25AA GWGSFFKKAA HVGKHVGKAA LTHYL // ID AMRSAPFCS73 PN Pleurocidins SO Winter flounder PL 24 TX Animalia (Pisces) PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 2, 'E': 0, 'F': 0, 'G': 7, 'H': 1, 'I': 4, 'K': 2, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 8.33%, 'C': 0%, 'D': 8.33%, 'E': 0%, 'F': 0%, 'G': 29.17%, 'H': 4.17%, 'I': 16.67%, 'K': 8.33%, 'L': 12.5%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 8.33%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 4.17%, 'Y': 0% MA C, E, F, M, N, P, Q, S, T, V, Y MO G LO H, W BA 17 LA 7 AA 2 BC 5 MC 0 MF 0 XX MM 2473.907 AI 122.083 II 28.046 HP 0.096 HM 0.84 IP 10.774 NC 2.089 SF 0.333, 0.292, 0.208 [Helix, Turn, Sheet] AR 0.042 ME 5500, 5500 MS 24.080516 XX SC alpha XX TO Staphylococcus aureus Methicillin resistant clinical isolate (MIC > 64 μG/mL) XX XR PubMed: 12950255 XR CAMP R4: NA SQ SEQUENCE 2473.907 DA MW 24AA GKGRWLDRIG KAGGIIIGGA LDHL // ID AMRSAPFCS74 PN Pleurocidins SO Winter flounder PL 21 TX Animalia (Pisces) PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 1, 'E': 1, 'F': 1, 'G': 3, 'H': 0, 'I': 3, 'K': 1, 'L': 1, AC 'M': 1, 'N': 2, 'P': 0, 'Q': 0, 'R': 1, 'S': 3, 'T': 1, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 9.52%, 'C': 0%, 'D': 4.76%, 'E': 4.76%, 'F': 4.76%, 'G': 14.29%, 'H': 0%, 'I': 14.29%, 'K': 4.76%, 'L': 4.76%, AF 'M': 4.76%, 'N': 9.52%, 'P': 0%, 'Q': 0%, 'R': 4.76%, 'S': 14.29%, 'T': 4.76%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, H, P, Q, V, W, Y MO G; I; S LO D, E, F, K, L, M, R, T BA 11 LA 10 AA 2 BC 2 MC 0 MF 0 XX MM 2181.448 AI 83.81 II 56.5 HP -0.052 HM 0.737 IP 6.494 NC -0 SF 0.238, 0.381, 0.238 [Helix, Turn, Sheet] AR 0.048 ME 0, 0 MS 12.040258 XX SC beta XX TO Staphylococcus aureus Methicillin resistant clinical isolate (MIC > 64 μG/mL) XX XR PubMed: 12950255 XR CAMP R4: NA SQ SEQUENCE 2181.448 DA MW 21AA RSTEDIIKSI SGGGFLNAMN A // ID AMRSAPFCS75 PN Pleurocidins SO Winter flounder PL 19 TX Animalia (Pisces) PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 3, 'G': 4, 'H': 3, 'I': 0, 'K': 0, 'L': 3, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 0, 'V': 1, 'W': 0, 'Y': 1 AF 'A': 10.53%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 15.79%, 'G': 21.05%, 'H': 15.79%, 'I': 0%, 'K': 0%, 'L': 15.79%, AF 'M': 0%, 'N': 5.26%, 'P': 0%, 'Q': 0%, 'R': 5.26%, 'S': 0%, 'T': 0%, 'V': 5.26%, 'W': 0%, 'Y': 5.26% MA C, D, E, I, K, M, P, Q, S, T, W MO G LO N, R, V, Y BA 13 LA 6 AA 0 BC 4 MC 0 MF 0 XX MM 2113.412 AI 87.368 II 7.079 HP 0.374 HM 0.591 IP 9.356 NC 1.27 SF 0.421, 0.263, 0.263 [Helix, Turn, Sheet] AR 0.211 ME 1490, 1490 MS 6.020129 XX SC alpha XX TO Staphylococcus aureus Methicillin resistant clinical isolate (MIC > 64 μG/mL) XX XR PubMed: 12950255 XR CAMP R4: NA SQ SEQUENCE 2113.412 DA MW 19AA FFRLLFHGVH HGGGYLNAA // ID AMRSAPFCS76 PN Pleurocidins SO Winter flounder PL 19 TX Animalia (Pisces) PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 3, 'G': 2, 'H': 3, 'I': 1, 'K': 2, 'L': 2, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 5.26%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 15.79%, 'G': 10.53%, 'H': 15.79%, 'I': 5.26%, 'K': 10.53%, 'L': 10.53%, AF 'M': 0%, 'N': 0%, 'P': 5.26%, 'Q': 0%, 'R': 10.53%, 'S': 0%, 'T': 0%, 'V': 10.53%, 'W': 0%, 'Y': 0% MA C, D, E, M, N, Q, S, T, W, Y MO F; H LO A, I, P BA 12 LA 7 AA 0 BC 7 MC 0 MF 0 XX MM 2259.734 AI 97.368 II -21.795 HP 0.1 HM 0.602 IP 12.532 NC 4.27 SF 0.421, 0.158, 0.158 [Helix, Turn, Sheet] AR 0.158 ME 0, 0 MS 24.080516 XX SC alpha XX TO Staphylococcus aureus Methicillin resistant clinical isolate (MIC = 64 μG/mL) XX XR PubMed: 12950255 XR CAMP R4: NA SQ SEQUENCE 2259.734 DA MW 19AA FFRLLFHGVH HVGKIKPRA // ID AMRSAPFCS77 PN Nisin SO Lactococcus lactis subsp. PL 57 TX Bacteria PE Experimentally validated XX AC 'A': 3, 'C': 5, 'D': 3, 'E': 0, 'F': 1, 'G': 4, 'H': 1, 'I': 3, 'K': 6, 'L': 4, AC 'M': 3, 'N': 3, 'P': 2, 'Q': 0, 'R': 1, 'S': 9, 'T': 6, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 5.26%, 'C': 8.77%, 'D': 5.26%, 'E': 0%, 'F': 1.75%, 'G': 7.02%, 'H': 1.75%, 'I': 5.26%, 'K': 10.53%, 'L': 7.02%, AF 'M': 5.26%, 'N': 5.26%, 'P': 3.51%, 'Q': 0%, 'R': 1.75%, 'S': 15.79%, 'T': 10.53%, 'V': 5.26%, 'W': 0%, 'Y': 0% MA E, Q, W, Y MO S LO F, H, R BA 23 LA 34 AA 3 BC 8 MC 0 MF 0 XX MM 5939.939 AI 68.421 II 28.886 HP -0.011 HM 0.313 IP 8.8 NC 3.779 SF 0.193, 0.316, 0.175 [Helix, Turn, Sheet] AR 0.018 ME 0, 250 MS 42.140903 XX SC alpha XX TO MRSA 831 Clinical isolate (MIC > 32 μM) XX XR PubMed: 33427970 XR CAMP R4: NA SQ SEQUENCE 5939.939 DA MW 57AA MSTKDFNLDL VSVSKKDSGA SPRITSISLC TPGCKTGALM GCNMKTATCN CSIHVSK // ID AMRSAPFCS78 PN Nisin SO Lactococcus lactis subsp. PL 57 TX Bacteria PE Experimentally validated XX AC 'A': 3, 'C': 5, 'D': 3, 'E': 0, 'F': 1, 'G': 4, 'H': 1, 'I': 3, 'K': 6, 'L': 4, AC 'M': 3, 'N': 3, 'P': 2, 'Q': 0, 'R': 1, 'S': 9, 'T': 6, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 5.26%, 'C': 8.77%, 'D': 5.26%, 'E': 0%, 'F': 1.75%, 'G': 7.02%, 'H': 1.75%, 'I': 5.26%, 'K': 10.53%, 'L': 7.02%, AF 'M': 5.26%, 'N': 5.26%, 'P': 3.51%, 'Q': 0%, 'R': 1.75%, 'S': 15.79%, 'T': 10.53%, 'V': 5.26%, 'W': 0%, 'Y': 0% MA E, Q, W, Y MO S LO F, H, R BA 23 LA 34 AA 3 BC 8 MC 0 MF 0 XX MM 5939.939 AI 68.421 II 28.886 HP -0.011 HM 0.313 IP 8.8 NC 3.779 SF 0.193, 0.316, 0.175 [Helix, Turn, Sheet] AR 0.018 ME 0, 250 MS 42.140903 XX SC alpha XX TO MRSA 839 Clinical isolate (MIC = 8 μM) XX XR PubMed: 33427970 XR CAMP R4: NA SQ SEQUENCE 5939.939 DA MW 57AA MSTKDFNLDL VSVSKKDSGA SPRITSISLC TPGCKTGALM GCNMKTATCN CSIHVSK // ID AMRSAPFCS79 PN Nisin SO Lactococcus lactis subsp. PL 57 TX Bacteria PE Experimentally validated XX AC 'A': 3, 'C': 5, 'D': 3, 'E': 0, 'F': 1, 'G': 4, 'H': 1, 'I': 3, 'K': 6, 'L': 4, AC 'M': 3, 'N': 3, 'P': 2, 'Q': 0, 'R': 1, 'S': 9, 'T': 6, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 5.26%, 'C': 8.77%, 'D': 5.26%, 'E': 0%, 'F': 1.75%, 'G': 7.02%, 'H': 1.75%, 'I': 5.26%, 'K': 10.53%, 'L': 7.02%, AF 'M': 5.26%, 'N': 5.26%, 'P': 3.51%, 'Q': 0%, 'R': 1.75%, 'S': 15.79%, 'T': 10.53%, 'V': 5.26%, 'W': 0%, 'Y': 0% MA E, Q, W, Y MO S LO F, H, R BA 23 LA 34 AA 3 BC 8 MC 0 MF 0 XX MM 5939.939 AI 68.421 II 28.886 HP -0.011 HM 0.313 IP 8.8 NC 3.779 SF 0.193, 0.316, 0.175 [Helix, Turn, Sheet] AR 0.018 ME 0, 250 MS 42.140903 XX SC alpha XX TO MRSA 1 Clinical isolate (MIC = 4 μM) XX XR PubMed: 33427970 XR CAMP R4: NA SQ SEQUENCE 5939.939 DA MW 57AA MSTKDFNLDL VSVSKKDSGA SPRITSISLC TPGCKTGALM GCNMKTATCN CSIHVSK // ID AMRSAPFCS80 PN Nisin SO Lactococcus lactis subsp. PL 57 TX Bacteria PE Experimentally validated XX AC 'A': 3, 'C': 5, 'D': 3, 'E': 0, 'F': 1, 'G': 4, 'H': 1, 'I': 3, 'K': 6, 'L': 4, AC 'M': 3, 'N': 3, 'P': 2, 'Q': 0, 'R': 1, 'S': 9, 'T': 6, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 5.26%, 'C': 8.77%, 'D': 5.26%, 'E': 0%, 'F': 1.75%, 'G': 7.02%, 'H': 1.75%, 'I': 5.26%, 'K': 10.53%, 'L': 7.02%, AF 'M': 5.26%, 'N': 5.26%, 'P': 3.51%, 'Q': 0%, 'R': 1.75%, 'S': 15.79%, 'T': 10.53%, 'V': 5.26%, 'W': 0%, 'Y': 0% MA E, Q, W, Y MO S LO F, H, R BA 23 LA 34 AA 3 BC 8 MC 0 MF 0 XX MM 5939.939 AI 68.421 II 28.886 HP -0.011 HM 0.313 IP 8.8 NC 3.779 SF 0.193, 0.316, 0.175 [Helix, Turn, Sheet] AR 0.018 ME 0, 250 MS 42.140903 XX SC alpha XX TO MRSA 2 Clinical isolate (MIC = 8 μM) XX XR PubMed: 33427970 XR CAMP R4: NA SQ SEQUENCE 5939.939 DA MW 57AA MSTKDFNLDL VSVSKKDSGA SPRITSISLC TPGCKTGALM GCNMKTATCN CSIHVSK // ID AMRSAPFCS81 PN Nisin SO Lactococcus lactis subsp. PL 57 TX Bacteria PE Experimentally validated XX AC 'A': 3, 'C': 5, 'D': 3, 'E': 0, 'F': 1, 'G': 4, 'H': 1, 'I': 3, 'K': 6, 'L': 4, AC 'M': 3, 'N': 3, 'P': 2, 'Q': 0, 'R': 1, 'S': 9, 'T': 6, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 5.26%, 'C': 8.77%, 'D': 5.26%, 'E': 0%, 'F': 1.75%, 'G': 7.02%, 'H': 1.75%, 'I': 5.26%, 'K': 10.53%, 'L': 7.02%, AF 'M': 5.26%, 'N': 5.26%, 'P': 3.51%, 'Q': 0%, 'R': 1.75%, 'S': 15.79%, 'T': 10.53%, 'V': 5.26%, 'W': 0%, 'Y': 0% MA E, Q, W, Y MO S LO F, H, R BA 23 LA 34 AA 3 BC 8 MC 0 MF 0 XX MM 5939.939 AI 68.421 II 28.886 HP -0.011 HM 0.313 IP 8.8 NC 3.779 SF 0.193, 0.316, 0.175 [Helix, Turn, Sheet] AR 0.018 ME 0, 250 MS 42.140903 XX SC alpha XX TO MRSA 3 Clinical isolate (MIC = 8 μM) XX XR PubMed: 33427970 XR CAMP R4: NA SQ SEQUENCE 5939.939 DA MW 57AA MSTKDFNLDL VSVSKKDSGA SPRITSISLC TPGCKTGALM GCNMKTATCN CSIHVSK // ID AMRSAPFCS82 PN Nisin SO Lactococcus lactis subsp. PL 57 TX Bacteria PE Experimentally validated XX AC 'A': 3, 'C': 5, 'D': 3, 'E': 0, 'F': 1, 'G': 4, 'H': 1, 'I': 3, 'K': 6, 'L': 4, AC 'M': 3, 'N': 3, 'P': 2, 'Q': 0, 'R': 1, 'S': 9, 'T': 6, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 5.26%, 'C': 8.77%, 'D': 5.26%, 'E': 0%, 'F': 1.75%, 'G': 7.02%, 'H': 1.75%, 'I': 5.26%, 'K': 10.53%, 'L': 7.02%, AF 'M': 5.26%, 'N': 5.26%, 'P': 3.51%, 'Q': 0%, 'R': 1.75%, 'S': 15.79%, 'T': 10.53%, 'V': 5.26%, 'W': 0%, 'Y': 0% MA E, Q, W, Y MO S LO F, H, R BA 23 LA 34 AA 3 BC 8 MC 0 MF 0 XX MM 5939.939 AI 68.421 II 28.886 HP -0.011 HM 0.313 IP 8.8 NC 3.779 SF 0.193, 0.316, 0.175 [Helix, Turn, Sheet] AR 0.018 ME 0, 250 MS 42.140903 XX SC alpha XX TO MRSA 4 Clinical isolate (MIC = 8 μM) XX XR PubMed: 33427970 XR CAMP R4: NA SQ SEQUENCE 5939.939 DA MW 57AA MSTKDFNLDL VSVSKKDSGA SPRITSISLC TPGCKTGALM GCNMKTATCN CSIHVSK //